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A bstract
The percentage of Alaska Natives who use smokeless tobacco (SLT) is 4 times that of non­
Native Alaskans and 45 times higher for Alaska Native women than non-Native women. The use 
of SLT is concentrated in Southwest Alaska where 32% of all adult Alaska Natives use SLT. Out 
of those users, 35% use only iqmik, a unique form of SLT in Alaska, which is a combination of 
tobacco leaf mixed with Phellinus igniarius (punk fungus). There is little evidence of the 
pathological effects of iqmik to assist in the development of an evidenced-based intervention 
regarding the harmful effects of iqmik. The current lack of evidence reinforces a belief that 
iqmik is less harmful than other tobacco alternatives. The overall objective of this thesis is to 
elucidate the effect of iqmik and iqmik-mediated metal exposure on oxidative stress and nuclear 
factor- k B (NF-k B) induced inflammation in human gingival epithelial cells. The central 
hypothesis of this thesis is that cadmium (Cd), cobalt (Co) and nickel (Ni) accumulate in human 
gingival epithelial cells from iqmik treatments, inducing oxidative stress and promoting an 
intracellular environment that alters NF-kB proinflammatory signaling targets. Our findings 
indicate that iqmik is a greater source of heavy metals, such as Cd, Co and Ni, than air-cured 
tobacco leaf. Human gingival epithelial cells accumulate more Cd, Co and Ni from the punk ash 
component of iqmik than from the air-cured tobacco. These metals have the capacity to 
accumulate in cells from iqmik treatments and generate and propagate the production of 
endogenous reactive oxygen species (ROS), which activates NF-k B significantly altering its 
signaling targets, more so than tobacco alone. The results of this thesis identify iqmik as a unique 
health hazard compared to other tobacco products and enhances our understanding of how iqmik 
may contribute to oral pathologies.
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Introduction
Cancer of the oral cavity is the sixth most common cancer in the world and it is especially 
prevalent in Alaska (1-3). Squamous cell carcinoma accounts for 90% of all oral cancers (4). 
Head and neck squamous cell carcinoma (HNSCC) is a significant problem because it has a poor 
5-year survival rate, which has not improved significantly over the last 30 years, and treatments 
can result in functional defects (5). Oral cancer is an aggressive cancer that commonly 
metastasizes to other organs. Early detection of oral lesions has a significant effect on survival 
rates. However, nearly half of patients diagnosed with oral cancer have already developed 
metastases prior to their diagnosis. Therefore, a new method for diagnosis is necessary to detect 
oral cancers in an earlier stage (6).
In the United States, 80-90% of head and neck cancers are attributed to tobacco and alcohol 
abuse (7). Tobacco and alcohol are important etiological agents in the development of HNSCC, 
and the International Agency for Research on Cancer (IARC) has concluded that smokeless 
tobacco (SLT) is carcinogenic and causes oral cancer (8-11). SLT users have a 4 - 6 times higher 
risk for developing oral cancer than non-users and risk of oral cancer increases with years of use 
in a dose-dependent manner (12).
Tobacco use is a significant risk factor for oral mucosal lesions, as well. Oral mucosal lesions, 
including leukoplakia, submucous fibrosis and oral lichen planus are common in SLT users and 
can develop with limited use (13). Although only a small percent of oral mucosal lesions 
transform into cancer with a malignant transformation rate of 12.1% (14), oral lesions precede 
the majority of oral cancers, with only approximately 30% of cases appearing de novo from 
histologically normal oral epithelium (15,16).
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In India, tobacco chewing is the strongest risk factor for oral cancer. The most common form 
of chewing tobacco in India is betel quid, a mixture of areca nut, slaked lime and tobacco in a 
betel leaf. This form of tobacco is a major cause of oral submucous fibrosis and oral leukoplakia 
(17). In India, oral leukoplakia was found to precede the development of oral cancer in 
approximately 70% of the cases (18,19).
Erythroplakia, a red lesion, leukoplakia, a white lesion which is the most common, and 
erythroleukoplakia are premalignant chronic non-healing epithelial ulcers. The extent of 
epithelial dysplasia in a lesion is classified as low or high-grade. Dysplasia and carcinoma is 
much more likely with erythroplakia than leukoplakia (9,20). Lesions with granular or verrucous 
appearance and located along the floor of the mouth or border of tongue are associated with high 
risk of malignant transformation (4).
Oral damage from SLT use, including premalignant lesions and malignant tumors, can be seen 
during a clinical examination, and visual inspection is the most common diagnostic tool for 
detecting oral cancers. However, this is not a sufficient method for detecting oral cancers as there 
is little evidence that this form of screening reduces the incidence or mortality from oral cancers 
(12,15). Therefore, molecular and biochemical techniques can provide more accurate 
information about the preneoplastic changes occurring in the oral cavity. A practical application 
of these markers needs to be implemented in the clinic so that a more accurate characterization of 
oral lesions can be performed to improve detection of those lesions that will go on to malignant 
transformation (15).
The incidence of oral cancer is estimated to be rising annually by 2.6% in Alaska and by 6.5% 
specifically for Alaska Natives. Alaska has an oral cancer, age-adjusted, incidence rate of 10.8 
cases per 100,000 per year, with an average of 71 cases per year. Alaska Natives have an oral
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cancer, age-adjusted, incidence rate of 16.0 cases per 100,000 per year. Oral cancer has a 
mortality rate of 2.8 cases per 100,000 per year in Alaska and Alaska Natives have a mortality 
rate of 6.1 cases per 100,000 per year (SEERS).
SLT is used by 6% of all adult Alaskans compared to the national average of only 5% of all 
adults. The percentage of Alaska Natives who use SLT is 4 times that of non-Native Alaskans 
and 45 times higher for Alaska Native women then non-Native women. The use of SLT is 
concentrated in Southwest Alaska where 32% of all adult Alaska Natives use SLT. Out of all 
adult Alaska Natives who use SLT, 35% use only iqmik, a unique form of SLT in Alaska (21). In 
Southwest Alaska up to 60% of pregnant women self-report using iqmik during pregnancy (22). 
Alaska Native women have been reported to switch from other tobacco products to iqmik during 
pregnancy because it is perceived that iqmik is a safer alternative (23). However, very little is 
known about the health effects of iqmik exposure and prevalence of HNSCC correlated to the 
specific use of iqmik is undefined.
Iqmik is a combination of tobacco leaf mixed with Phellinus igniarius (punk fungus). The 
fungus is collected, air-dried and then burned to fine white ash. The ash is then mixed with air- 
cured leaf tobacco by mastication (24,25). Punk fungus has a higher concentration of alkali and 
alkaline earth metals compared to tobacco leaf, increasing the alkaline pH of iqmik, most likely 
accounting for the higher nicotine levels seen is users (25,26). Iqmik users have a nicotine intake 
two times that of cigarette smokers and greater than commercial SLT users (27). An alkaline pH 
converts nicotine, an alkaloid, from an ionized form to an un-ionized form that easily passes 
through biological membranes (28). This increases both the absorption and addictiveness of the 
nicotine (25,26,29).
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The addition of the slaked lime to betel quid in India also increases the mean pH of the 
mixture to pH10, inducing the generation of reactive oxygen species (ROS) from the areca nut. 
The slaked lime also causes ulceration of the oral mucosa. The combination of open wounds and 
ROS may provide a mechanism for the development of leukoplakia that is more prone to 
malignant transformation (17,18,30). Whether this occurs with iqmik use is unknown.
The ash in iqmik is also a source of higher levels of pro-inflammatory toxic metals than cured 
leaf tobacco. The levels of copper (Cu), iron (Fe), manganese (Mn), cadmium (Cd), chromium 
(Cr), nickel (Ni) and lead (Pb) are 2 - 80 times higher in the ash compared to leaf tobacco (25). 
In addition, more cobalt (Co), Ni and Cd can be extracted from mixtures of ash and leaf tobacco 
than from leaf tobacco alone when extracted with artificial human saliva (31).
The IARC classifies Cd and Ni as group 1 human carcinogens and Co as a group 2B 
carcinogen (32-34). Cd, Ni and Co exist as divalent cations in aqueous solution with similar 
ionic radii to Calcium (Ca), Magnesium (Mg) and Zinc (Zn) ions, respectively. Cd, Ni and Co 
can pass through cell membranes by utilizing cation transporters, and interfere with the structure 
and function of proteins and enzymes when they substitute for Ca, Mg and Zn ions, respectively 
(35).
Oxidative stress, induced by endogenous or exogenous insults, such as iqmik, is the 
cumulative result of an imbalance between ROS production and antioxidant defense. Metal- 
toxicity can cause oxidative stress, which is one of the mechanisms for the carcinogenic effects 
of metals (35-38). Co and Ni are involved in redox reactions that produce ROS. Cd inhibits 
antioxidant enzymes, catalase, superoxide dismutase, glutathione reductase and glutathione 
peroxidase, by binding to their thiol groups, leading to elevated ROS which is involved in 
oxidative damage to DNA, lipids and proteins (39). ROS can damage DNA through base
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modification leading to a mutagenic event, and subsequent tumor formation (35,37,40).
Oxidative stress can also cause up-regulation of signaling cascades that activate redox-regulated 
transcription factors, such as, AP-1, NF-k B, p53, NFAT and HIF-1. The genes regulated by these 
transcription factors are involved in DNA repair, inflammation, cell cycle arrest and apoptosis, 
processes involved in malignant transformation (35,37,40).
Redox-regulated NF-k B is the major inflammatory transcription factor that has a central role 
in many stress responses, regulating the transcription of various genes involved in inflammation, 
proliferation and cell survival (35,37). Overexpression of NF-k B may be involved in the 
development and progression of malignancies in multiple sites, including the oral cavity (5). NF- 
k B can be activated in oral epithelial cells exposed to khaini, a product similar to betel quid that 
is a tobacco and slaked lime mixture, with a very alkaline pH, used in India (41-43). The 
activation of NF-k B and the increased expression of NF-k B - regulated genes by iqmik are 
unknown.
The NF-k B regulated gene PTGS2, which encodes cyclooxygenase-2 (COX2) shows increased 
expression in oral epithelial cells exposed to an extract of khaini (42-45). COX2, a crucial 
enzyme in the biosynthesis of prostaglandins, is a key mediator of inflammation and is expressed 
by epithelial cells upon injury (42,46,47). Aberrant expression and activity of COX2 are causally 
involved in tumor promotion and progression (48). COX2 is expressed at high levels in many 
carcinomas, including HNSCC, as are other targets of NF-k B, such as interleukin (IL) -6  and IL- 
8 (49). NF-k B dependent cytokines, IL-1, IL-6 , IL-8  and TNFa are elevated in tissue samples 
from oral squamous cell carcinoma and in saliva samples from patients with either HNSCC or 
oral premalignant lesions (50-52). Establishing a set of biomarkers, such as these NF-k B 
regulated targets, that is consistent and biologically relevant for a population would more easily
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and accurately identify patients within that population that will go on to develop oral cancer 
(15,53).
The lack of information on the effects of iqmik on oral epithelial cells either before or after 
transformation prevents the establishment of an Alaska relevant set of biomarkers that could be 
used as a screening tool for the early identification of a premalignant state in SLT users. This gap 
in our knowledge raises the question, does an SLT like iqmik, which contains both punk ash and 
tobacco leaf, promote an environment of oxidative stress and inflammation that could favor the 
development of oral cancer? Specifically, does iqmik exposure produce endogenous ROS and 
trigger inflammatory signaling networks through the upregulation of NF-k B regulated gene 
products? Finally, could those responses be used to identify an early detection method for 
reducing oral cancers mortality rates in the Alaska Native population, the primary users of 
iqmik?
There is little evidence of the pathological effects of iqmik to assist in the development of an 
evidenced-based intervention regarding the harmful effects of iqmik. The current lack of 
evidence reinforces a belief that iqmik is less harmful than other tobacco alternatives (54-56).
The results of this thesis will add to the understanding of the biological basis for the health 
conditions associated with the use of iqmik, principally, defining the changes in cellular 
environment induced by iqmik exposure and enhancing our understanding of how iqmik may 
contribute to oral pathologies.
The overall objective of this thesis was to elucidate the effect of iqmik and iqmik-mediated 
metal exposure on oxidative stress and NF-k B induced inflammation in human gingival 
epithelial cells. The central hypothesis of this thesis was that Cd, Co and Ni would accumulate in 
human gingival epithelial cells from iqmik treatments, inducing oxidative stress and promoting
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an intracellular environment that alters NF-k B proinflammatory signaling targets. The following 
objectives were conducted to test this hypothesis.
The first objective of this thesis was to characterize the bioavailable concentrations of Cd, Co 
and Ni in iqmik and its components punk ash and tobacco leaf, and determine the relative 
contribution of these components and the metals within them to ROS generation in exposed 
human oral epithelial cells. We hypothesized that exposure of oral epithelial cells to artificial 
saliva extracts of iqmik would lead to absorption of cadmium, cobalt and nickel and would cause 
elevated ROS. The second objective of this thesis was to investigate the impact of tobacco and 
iqmik exposure on the expression of NF-k B signaling target genes in differentiated human oral 
epithelial cells. We hypothesized that iqmik would differentially alter the expression profile of 
NF-k B regulated genes compared to tobacco leaf alone. The final objective of this thesis was to 
propose a study to identify proinflammatory biomarkers for oral cancer in tobacco users in 
Alaska, which could be used to develop an accurate method for earlier detection of oral cancer in 
iqmik users. We hypothesize there will be a difference in proinflammatory cytokines expressed 
in whole unstimulated saliva among users of tobacco types in Alaska and those with oral cancer.
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C hapter 1. Exposure to smokeless tobacco m ixture iqmik leads to transition metals 
accumulation and reactive oxygen species production in hum an gingival epithelial cells1 
A bstract
Smokeless tobacco (SLT) users have 4-6 times higher risk for developing oral cancer than non­
users. The percentage of Alaska Native peoples who use SLT is nearly four times that of other 
Alaskans. Of all adult Alaska Native peoples who use SLT, 35% use only iqmik, an Alaska- 
specific SLT variant of tobacco leaf mixed with punk fungus ash. A previous analysis of punk 
ash and tobacco leaf suggested that ash contains higher levels of Cd, Co and Ni. However, the 
bioavailability of these metals and the impact tobacco leaf, punk ash or iqmik may have on the 
intracellular redox response in primary human gingival epithelial cells is unknown. We therefore 
determined the bioavailability of these metals in air-cured tobacco leaf, punk ash and iqmik, as 
well as the level of reactive oxygen species (ROS) produced in primary human gingival 
epithelial cells exposed to these compounds. Significantly higher concentrations of Cd, Co and 
Ni were isolated in punk ash and iqmik than in tobacco leaf. Artificial saliva extracts of iqmik 
produced a greater than additive ROS response compared to extracts of the individual 
components of iqmik, tobacco leaf and punk ash. Exposure to Co alone produced significantly 
more ROS than either Cd or Ni alone, suggesting that Co within the ash component of iqmik 
may have a greater contribution to the significantly higher ROS seen following iqmik exposure.
1 Dwyer, G.K., Hagedorn, B., Knall, C. (2015). Exposure to smokeless tobacco mixture iqmik 
leads to transition metals accumulation and reactive oxygen species production in human 
gingival epithelial cells. Submitted to the journal Carcinogenesis.
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1.1 Sum m ary
Iqmik, an Alaska specific smokeless tobacco product, is a greater source of carcinogenic heavy 
metals, such as Cd, Co and Ni, which have the capacity to accumulate in oral epithelial cells 
inducing the accumulation of endogenous ROS.
1.2 Introduction
Tobacco use is a significant risk factor for oral diseases, specifically oral mucosal lesions, 
periodontal disease and oral cancers. The International Agency for Research on Cancer (IARC) 
recently concluded that there is a causal association between smokeless tobacco (SLT) and oral 
cancer (1). SLT users have a 4-6 times higher risk for developing oral cancer than non-users and 
risk of oral cancer increases with years of use. Head and neck squamous cell carcinoma is the 
sixth most common cause of death from cancer in the world, and it is especially prevalent in 
Alaska (2-5). In the United States 80-90% of head and neck cancers are attributed to tobacco and 
alcohol abuse (6). Tobacco and alcohol are identified as important etiological agents in the 
development of head and neck squamous cell carcinoma (7-9).
SLT is used by 6% of all adult Alaskans compared to the national average of only 5% of all 
adults. The percentage of Alaska Native peoples who use SLT is four times that of non-Native 
Alaskans. The use of SLT is concentrated in Southwest Alaska where 32% of all adult Alaska 
Native persons use SLT. Out of all adult Alaska Native persons who use SLT, 35% use only 
iqmik, a unique form of SLT used in Alaska (10). Iqmik is a combination of tobacco leaf mixed 
with Phellinus igniarius (punk fungus). The fungus is collected, air-dried and then burned to fine 
white ash. The ash is then mixed with the air-cured leaf tobacco by mastication (11,12).
Punk fungus has a higher concentration of alkali and alkaline earth metals compared to 
tobacco leaf, increasing the alkaline pH of iqmik (12,13). The ash is also a source of higher
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levels of pro-inflammatory toxic metals than cured leaf tobacco. The levels of copper (Cu), iron 
(Fe), manganese (Mn), cadmium (Cd), chromium (Cr), nickel (Ni) and lead (Pb) are 2-80 times 
higher in the ash compared to leaf tobacco (12). In addition, more cobalt (Co), Ni and Cd can be 
extracted from mixtures of ash and leaf tobacco than from leaf tobacco alone when extracted 
with artificial human saliva (14). The International Agency for Research on Cancer classifies Cd 
and Ni as group 1 human carcinogens and Co as a group 2B carcinogen (15-17). Cd, Ni and Co 
exist as divalent cations in aqueous solution with similar ionic radii to Calcium (Ca), Magnesium 
(Mg) and Zinc (Zn) ions, respectively. Cd, Ni and Co can pass through cell membranes by 
utilizing cation transporters, and interfere with the structure and function of proteins and 
enzymes when they substitute for Ca, Mg and Zn ions, respectively (18).
Oxidative stress, induced by endogenous or exogenous insults, such as iqmik, is the 
cumulative result of an imbalance between reactive oxygen species (ROS) production and 
antioxidant defense. Metal toxicity can cause oxidative stress, which is one of the mechanisms 
for the carcinogenic effects of metals (18-21). Co and Ni are involved in redox reactions that 
produce ROS. Cd inhibits antioxidant enzymes, catalase, superoxide dismutase, glutathione 
reductase and glutathione peroxidase, by binding to their thiol groups, leading to elevated ROS 
which is involved in oxidative damage to DNA, lipids and proteins (22). ROS can damage DNA 
through base modification leading to a mutagenic event, and subsequent tumor formation 
(18,20,23). These changes in turn cause up-regulation of signalling cascades activating redox- 
regulated transcription factors, such as, AP-1, NF-k B, p53, NFAT and HIF-1. The genes 
regulated by these transcription factors are involved in DNA repair, inflammation, cell cycle 
arrest and apoptosis (18,20,23). This study was designed to characterize the bioavailable 
concentrations of Cd, Co and Ni in iqmik and its components punk ash and tobacco leaf, and
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determine the relative contribution of these components and the metals within them to ROS 
generation in exposed human oral epithelial cells.
1.3 M aterials and methods
1.3.1 Iqmik, punk ash and air-cured tobacco preparation, extraction and p H  determination 
Following community practice for iqmik preparation without mastication (Renner, Personal 
Communication), air-cured whole leaf tobacco was cut into small homogeneous pieces using a 
coffee bean grinder. Punk fungus was sawed into pieces weighing 300g or less, placed into a 
metal coffee can and ashed on a hot plate set on high. Punk ash was weighed out to 1g for all 
punk ash extracts; air-cured tobacco leaf was weighed out to 1g for all tobacco extracts. Iqmik 
extracts were prepared by combining 0.5g punk ash and 0.5g tobacco. Artificial human saliva 
was prepared with 5.3mM KSCN, 15mM NaHCOs, 20mM KCl, 1.4mM N H 2PO4, 0.1g/L 
CH4N2O (urea), and 0.1mg/L a-amylase. Each sample (1g) was extracted in 25mL artificial 
human saliva. Each sample was inverted 7 times and incubated for 30 minutes at 37°C and 5% 
CO2. Samples were centrifuged for 10 minutes at 2 0 0 0  x g, the supernatant was removed from 
the solid phase, and filter sterilized (14). For pH determination, prepared extracts in triplicate 
were either undiluted or diluted 1:1 with CnT-32 Oral Epithelium Medium (CELLnTEC 
Advanced Cell Systems AG, Bern, Switzerland) containing CaCl2 (1pM) and measured with an 
Oakton pH meter (Oakton Instruments, Vernon Hills, IL) equipped with a Orion probe (Thermo 
Scientific, Waltham, MA) at room temperature,
1.3.2 Cell culture and differentiation
Primary human gingival epithelial cells (HGEP) (CELLnTEC) were cultured for use in the 
experiments. Cultures were maintained at a seeding density of 4.0 x 103 cells per cm2 in CnT-24 
PCT Oral Epithelium Medium (CELLnTEC). For cultures to be exposed, cells were grown for
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approximately 6-8 days in CnT-24 PCT Oral Epithelium Medium until one day prior to 
confluency at which time the medium were changed to CnT-32 Oral Epithelium Medium 
(CELLnTEC). Cultures were grown for an additional 24 hours and then induced to differentiate 
in CnT-32 containing CaCl2 (1^M) (differentiation media) per manufactures directions. Cells to 
be exposed were cultured in differentiation media for 96hrs before all experimental procedures.
1.3.3 Cell viability
The Live/Dead Cell Assay (Molecular Probes, Life Technologies, Carlsbad, CA) was used to 
determine viability of exposed differentiated HGEP. Differentiated HGEP were exposed to 
artificial saliva, artificial saliva extracts of iqmik, air-cured tobacco or punk ash and extracts 
diluted 1:1 in differentiation media for 24 hours. Treated differentiated HGEP were then 
incubated with live dye, calcein AM (1pM), and dead dye, ethidium homodimer-1 (2pM) for 30 
minutes. Control differentiated HGEP were incubated in differentiation media (live control), or 
methanol (70%) (dead control) for 45 minutes. Cell viability was quantified as fluorescence 
intensity using a fluorescence microplate reader (Molecular Devices, Sunnyvale, CA) (Data not 
shown).
1.3.4 Metals quantification
Metals quantification was accomplished using the Environmental Protection Agency (EPA) 
method 3051A (24) for sample digestion followed by inductively coupled plasma mass 
spectrometry (ICPMS) analysis.
1.3.4.1 Sample preparation. Triplicate samples of 1g compounds iqmik, air-cured tobacco and 
punk ash were dried and weighed to 1mg accuracy prior to digestion. Artificial saliva extracts of 
air-cured leaf tobacco, punk ash and iqmik were prepared as described above and aliquoted into 
2ml for digestion. To measure metals accumulation in cells, differentiated HGEP, plated on
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100mm plates, were washed with phosphate buffered saline (PBS) and then exposed to artificial 
saliva, or artificial saliva extracts of iqmik, tobacco, or punk ash diluted 1:1 with differentiation 
media for 24 hours prior to digestion. Following exposure, cells were washed with PBS and 
lysed with 1mL Mg lysing buffer (25mM Hepes pH 7.5, 150mM NaCl, 1% Igepal CA-630, 
0.25% NaDOC, 10% glycerol, 25mM NaF, 10mM MgCh, 1mM EDTA, 1mM Na3VO4,
10pg/mL lupeptin, 10mg/mL aprotinin). The majority of the lysate (975pL) was used for 
digestion. The remaining portion of the lysate (25pL) was used in a RC DC Protein Assay 
(BioRad Laboratories, Hercules, CA) to standardize intracellular metals concentration to total 
protein concentration.
1.3.4.2 Digestion. Five mL of trace metal grade concentrated HNO3 (J.T. Baker - Advantor, 
Center Valley, PA) was added to each sample and kept at room temperature overnight. Five mL 
of trace metals grade H2O (> 18 MQ-cm) was added to each sample, followed by microwave 
assisted pressure digestion at 180 in a Milestone Ethos model microwave system (Shelton, CT) 
with a 10 minute hold at 180°C. Following digestion, 1mL of Tamapure AA-10 H2O2 (35%, 
Moses Lake Industries, Moses Lake, WA) was added to each sample while being heated at 
180°C. The samples were then evaporated to near dryness over 3 hours and rehydrated in 10mL 
of 1% HNO3 for the iqmik and components digest and in 2mL 1% HNO3 for artificial saliva 
extracts and cell digest, and filtered (0.45pm) before analysis. Blanks were prepared in triplicate 
as described, but without the addition of experimental samples.
1.3.4.3 ICP-MSanalysis. Analysis of metals in iqmik, air-cured tobacco and ash compounds was 
performed in the Applied Science, Engineering, and Technology (ASET) Laboratory at 
University of Alaska Anchorage using an Agilent 7500c ICP-MS with collision cell and AX 500 
CETAC Technologies autosampler. Measurements were carried out at 1480 with Argon plasma
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flow at 15L min-1, carrier gas flow of 1.2mL min-1 and makeup gas flow at 0.2mL min-1. Cd, Co, 
and Ni were analyzed in normal mode (no reaction gas). External seven level calibration at 0.5,
1, 5, 10, 50, 100^g L-1 was prepared from Agilent standard I stock solution (Agilent ®). To 
correct for instrument drift internal standard composed of Li(7), Sc, Y, In, and Bi was used at 
10ug L-1 concentration (Agilent ®) was used for quantification. Calibration verification was 
performed every ten samples and international standard NIST SRM 1643e was used to verify 
calibration solutions; all values above 90% recovery were accepted. Limit of detection was 
calculated from regression analysis of calibration as outlined by Harris (25). Analysis of metals 
in the saliva extracts and HGEP samples was performed by the Elemental Analysis Core at 
Oregon Health Science University (OHSU) using an Agilent 7700x equipped with an ASX 250 
autosampler. The system was operated at a radio frequency power of 1550W, an argon (Ar) 
plasma gas flow rate of 15L/min, and Ar carrier gas flow rate of 1.08L/min. Co and Ni were 
measured in kinetic energy discrimination (KED) mode using He gas (4.2mL/min) and Cd was 
measured in no-gas mode. For measurement, 2x dilutions of samples were prepared in 1% HNO3 
(trace metal grade, Fisher Scientific) in acid-treated 15mL conical tubes, via incubation in 1% 
HNO3 for at least 24 hours. Data were quantified using a 10-point calibration curve (0, 0.25, 0.5, 
1, 2, 5, 10, 50, 100, 1000 ppb (ng/g)) with external standards for Co, Ni, and Cd (Common 
Elements Mix 1 Multi-Element Aqueous Standard, VHG Labs) in 1% HNO3. For each sample, 
data were acquired in triplicate and averaged. An internal standard (Internal Standard Multi­
Element Mix 3, VHG Labs) introduced with the sample was used to correct for plasma 
instabilities, and frequent measurements of a 5 ppb all-analyte solution as well as a blank 
(containing 1% HNO3 only) were used as quality control and to determine the coefficient of 
variance. To access recovery rates of elements and probe background contamination from
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containers, a certified NIST standard reference material control was treated, prepared, and 
analyzed by the same method as the samples (trace metals in water, SRM 1643e).
1.3.5 ROS measurement
ROS was assessed by a procedure modified by Mitchell et al. (26). Briefly, total ROS was 
measured with membrane permeable oxidation-sensitive fluorescent dye H2DCFDA (Invitrogen, 
Life Technologies) in differentiated HGEP following manufacturer’s directions. Differentiated 
HGEP in 96-well plates were washed with PBS and incubated for 1 hour with H2DCFDA 
(15pM), or PBS only (no dye control), washed with PBS and incubated for an additional 30 min 
in differentiation media alone. Following a PBS wash, labeled and control differentiated HGEP 
were exposed to artificial saliva, artificial saliva extracts of iqmik, air-cured tobacco or punk ash, 
or hydrogen peroxide (100pM) (ROS positive control, data not shown) for 3 hours at 37°C and 
5% CO2 followed by quantification of DCF-fluorescence intensity by fluorescence microplate 
reader (Molecular Devices) (26). To determine the extent of ROS production by Co, Ni or Cd 
alone, labeled and control differentiated HGEP were exposed to CoCl2 (1mg/L), NiCl2 (1mg/L) 
or CdCl2 (1mg/L) in artificial saliva diluted 1:1 with differentiation media. Each treatment was 
tested in triplicate.
1.3.6 Statistical analysis
All reported results represent the mean ± SEM of data obtained in three independent 
experiments. Statistical analysis was performed with the one-way ANOVA and Tukey’s HSD 
post hoc tests. P  < 0.05 was considered statistically significant.
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1.4 Results
1.4.1 Trace metals concentration in air-cured tobacco leaf, punk ash and iqmik
Total concentrations of Cd, Co and Ni in air-cured tobacco, punk ash and iqmik are reported in 
Figure 1.1. All samples reported above the limit of detection of the Agilent 7500c ICP-MS. Punk 
ash samples had significantly higher concentration of Cd (P < 0.0001), Ni (P < 0.0001) and Co 
(P < 0.0055) than air-cured leaf tobacco. Iqmik samples also had significantly higher 
concentration of Cd (P < 0.0002) and Ni (P < 0.002) than air-cured leaf tobacco. Punk ash 
samples had significantly higher concentrations of Cd (P < 0.0006) and Ni (P < 0.0011) than 
iqmik. It should be noted that iqmik was made of equal weights air-cured tobacco and ash, and 
thus contained only half the quantity of punk ash and leaf tobacco that was used to determine the 
concentration of metals (pg/g total weight) in each sample of the constituent compounds.
1.4.2 p H  o f  artificial saliva extracts
Because of the previously reported (12,13) alkaline nature of punk ash and iqmik, we determined 
the pH for the artificial saliva extracts of punk ash, tobacco and iqmik (Table 1.1). The pH of 
artificial saliva extracts of punk ash undiluted and diluted (P < 0.0001, P  < 0.0001 respectively) 
was significantly more alkaline than the pH of the artificial saliva extracts of air-cured tobacco 
leaf. Therefore, the pH of the artificial saliva extracts of iqmik was primarily influenced by the 
punk ash component.
1.4.3 Trace metals concentration in artificial saliva extracts o f  air-cured tobacco leaf, punk ash 
and iqmik
To determine the extent to which trace metals from the tobacco leaf, punk ash and iqmik would 
be extracted by the artificial saliva, ICP-MS analysis was performed on each of the artificial 
saliva extracts (Figure 1.2). Co and Ni were extracted from air-cured tobacco leaf, punk ash and
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iqmik by the artificial saliva. Cd was extracted from air-cured tobacco leaf and iqmik, but not 
punk ash by the artificial saliva. Air-cured tobacco saliva extracts had significantly more Cd (P < 
0.0001) and Co (P < 0.0002) than punk ash saliva extracts. Iqmik saliva extracts had 
significantly more Cd (P < 0.001), Ni (P < 0.0001) and Co (P < 0.0002) than punk ash saliva 
extracts. Punk ash saliva extracts had significantly more Ni (P < 0.0001) than air-cured tobacco 
saliva extracts. The extraction efficiency for Cd, Ni and Co in the artificial saliva extracts was 
determined as a percentage of the metals in the extracts compared to the metals available in the 
corresponding digest of whole air-cured tobacco, punk ash and iqmik (Table 1.2). Artificial 
saliva extracts of air-cured tobacco leaf had the highest extraction efficiency for Co and Cd, 
whereas, iqmik had the highest extraction efficiency for Ni. Punk ash had the lowest extraction 
efficiency for all three metals tested.
1.4.4 Trace metal concentration in exposed HGEP
Differentiated HGEP exposed for 24 hours to artificial saliva extracts of air-cured tobacco, punk 
ash or iqmik diluted 1:1 in differentiation media showed metals absorption for Co, Ni and Cd in 
cultures exposed to either punk ash or iqmik (Figure 1.3). Cd was the only metal that 
accumulated in HGEP cells exposed to artificial saliva extracts of air-cured tobacco leaf, and this 
accumulation was not statistically different (P < 0.88) from that in HGEP exposed to artificial 
saliva. HGEP exposed to artificial saliva extracts of punk ash showed significantly more Cd (P < 
0.03, iqmik, P  <0.0068, tobacco leaf, P  <0.0028, saliva), Ni (P < 0.0001, all) and Co (P <
0.0001, all) accumulation than HGEP treated with either artificial saliva extracts of iqmik or air- 
cured tobacco. HGEP exposed to artificial saliva extracts of iqmik did show a significant Cd (P <
0.3), Ni (P < 0.81) or Co (P < 0.63) accumulation than HGEP treated with artificial saliva.
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1.4.5 Cell viability o f  exposed differentiated HGEP
To determine the effect on cell viability of the artificial saliva, artificial saliva extracts of 
tobacco, punk ash or iqmik and the artificial saliva and artificial saliva extracts diluted 1:1 in 
differentiation media, differentiated HGEP cells were exposed for 24 hours to these various 
samples. The cells exhibited less cytotoxic response in the iqmik (P < 0.2) and artificial saliva (P 
< 0 .0 0 0 1 ) samples treated with extracts diluted 1:1 in differentiation media compared to the 
samples treated with pure extract. HGEP cells treated with artificial saliva extracts of iqmik 
diluted 1:1 in differentiation media exhibited significantly less cytotoxic response (P < 0.0001) 
than the control dead samples (Data not shown).
1.4.6 ROS production in exposed differentiated HGEP
As a measure of oxidative stress in differentiated HGEP exposed to artificial saliva extracts of 
iqmik, tobacco leaf or punk ash, ROS was measured (Figure 1.4A). Artificial saliva extracts of 
iqmik (P < 0.0001) or air-cured tobacco leaf (P < 0.0092) produced significantly more ROS in 
exposed cells than artificial saliva extracts of punk ash. Artificial saliva extracts of punk ash 
produced back ground levels similar to artificial saliva alone (P < 0.52). Artificial saliva extracts 
of air-cured tobacco leaf (P < 0.0058) and iqmik (P < 0.0001) produced significantly more ROS 
in exposed HGEP than artificial saliva alone.
The ability of Cd, Co or Ni alone to produce ROS in exposed differentiated HGEP was 
determined by exposing cells to 1mg/L of CoCl2, NiCl2 or CdCl2 in artificial saliva diluted 1:1 in 
differentiation media (Figure 1.4B). Co exposure produced a significantly higher ROS response 
than the artificial saliva control (P < 0.0001), Cd (P < 0.0001) or Ni (P < 0.0001) exposures. Cd 
(P < 0.97) and Ni (P < 0.74) treatments produced similar levels of ROS compared to the artificial 
saliva control.
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1.5 Discussion
As previously identified by Pappas et al., (14) punk ash has significantly more Cd, Co and Ni 
than the air-cured tobacco leaf, accounting for the elevated levels of carcinogenic metals in 
iqmik. The extraction efficiency of Cd, Co and Ni is pH dependent. In an alkaline solution, Cd, 
Co and Ni form insoluble hydroxide salts (27). This trend is evident when comparing the 
concentrations of metals in artificial saliva extracts of iqmik, air-cured tobacco and punk ash. 
Studies of other alkaline ash extracts have shown similar results. Cd is minimally soluble 
between pH ranges 10.5 and 13 in fly ash (28). The pH of the punk ash extracts and iqmik 
extracts are just outside the range of minimal solubility for Cd. Based on the similarity of 
solubility constants for the metal hydroxides, Co and Ni are likely to have similar pH ranges for 
solubility. This is further confirmed by the fact that punk ash has a higher concentration of 
metals than air-cured tobacco alone (Figure 1.1), but the alkaline artificial saliva extracts of punk 
ash have lower levels of Cd and Co than artificial saliva extracts of air-cured tobacco (Figure 
1.2). The minimal risk levels for Cd, Co and Ni published by the Agency for Toxic Substances 
and Disease Registry are 0.0005 mg/kg/day intermediate oral exposure and 0.0001 mg/kg/day 
chronic oral exposure for Cd, 0.01 mg/kg/day intermediate oral exposure for Co, 0.0002 mg/m3 
intermediate inhaled exposure and 0.00009 mg/m3 chronic inhaled exposure for Ni. Intermediate 
exposure is 15-364 days; chronic exposure is greater than 1 year. The minimal risk level for Ni 
from oral exposure has not been determined, but water sources have a median Ni range of 0.5 to 
6 pg/L. The US Environmental Protection Agency requires drinking water to have less than 5 
pg/L of Cd, and the average reported level of Co in drinking water is 2 pg/L. A 30 min artificial 
saliva extract of iqmik contains 1/3 of the maximum recommended amount of Cd in drinking
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water, and exceeds the normal amount of Co and Ni in drinking water by 5 -  10 fold, 
respectively (29-31).
The accumulation of metals by the cells is a very different trend than the saliva extraction 
efficiencies. HGEP exposed to punk ash extracts have the greatest metal absorption for Cd, Co 
and Ni. Active transport of the metals into the cells occurs primarily in the punk ash and iqmik 
saliva extract treated HGEP. The pH of the punk ash and iqmik saliva extracts are both basic, to 
compensate for the alkalinity of the external environment the HGEP would try to maintain an 
internal environment that is close to physiological pH. To maintain a more neutral internal 
environment a net internal accumulation of H+ must occur (32,33). Na+/H+ antiporters are 
actively involved in intracellular homeostasis, but in an alkaline environment the antiporter must 
be electrogenic rather than electroneutral. The internal transmembrane electrical gradient must be 
negative to support a larger influx of H+ to a small efflux of Na+ (33). The negative internal 
environment created within the cell may be influencing the transport of divalent transition metals 
across the cell membrane. Divalent metals can move across the membrane by a group of 
transporters that make up the SLC1 family. The SLC1 family uses the H+ electrochemical 
gradient to transport a broad range of divalent metal ions including Fe2+, Cd2+, Co2+, Ni2+, Zn2+, 
and Pb2+; many of the transporters in the family function as cotransporters (34-36). It is possible 
that the alkaline external environment created by the exposure to punk ash or iqmik saliva 
extracts promotes the accumulation of Cd, Co and Ni in HGEP.
Exposure of HGEP to air-cured tobacco or iqmik artificial saliva extracts results in 
significantly more ROS generation than artificial saliva alone. The air cured tobacco extracts are 
similar to hydrogen peroxide, but iqmik extracts produce significantly more ROS than hydrogen 
peroxide. Exposure to punk ash alone does not significantly increase ROS over artificial saliva.
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Levels of ROS seen in cells exposed to iqmik artificial saliva extracts are greater than the sum of 
ROS produced upon exposure with punk ash and air-cured tobacco artificial saliva extracts when 
corrected for artificial saliva alone, suggesting a synergistic effect. This is even more compelling 
because iqmik is only half the total punk ash and air-cured tobacco that elicits the ROS response 
seen in Figure 1.4. In regards to the relative contribution of each metal, Cd, Co, and Ni, in ROS 
formation in differentiated HGEP, Co exposure produces significant levels of ROS similar to the 
level in iqmik, and 10 times that seen with saliva alone. The concentration of Co that 
differentiated HGEP are exposed to in artificial saliva extracts of iqmik is likely contributing to 
the high levels of ROS produced.
Heavy metals, such as Cd, Co and Ni, are carcinogenic and have many mechanisms for 
participating in carcinogenesis, including oxidative damage to cellular proteins and DNA, as well 
as inhibiting the repair of damaged DNA. Cd, Co and Ni all contribute to the production of free 
radicals in cells. Many divalent metals participate in a Fenton-like reaction to produce free 
radicals in cell (37,38). Cd also binds to sulfhydryls like glutathione thus depleting glutathione 
stores, contributing to its toxicity and allowing ROS to propagate in the cell (20). It has been 
demonstrated in cell cultures that Cd, Ni and Co compete with zinc in zinc finger motifs, some of 
which are integral to the DNA repair process (39,40).
The main events leading to cancer are genetic alteration, chronic inflammation and malignant 
transformation and ROS generation is associated with all these conditions (38). Oral squamous 
cell carcinoma (OSCC) patients have raised levels of ROS and reactive nitrogen species (RNS) 
in their saliva and the salivary antioxidant content is significantly reduced compared to healthy 
controls. The salivary DNA and proteins are more oxidized in OSCC patients then healthy 
controls and the combination of ROS, RNS and depleted antioxidants promotes OSCC. (41-43).
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In summary, iqmik is a greater source of heavy metals, such as Cd, Co and Ni, than air-cured 
tobacco leaf. HGEP accumulate more Cd, Co and Ni from the punk ash component of iqmik than 
from the air-cured tobacco. These metals are identified carcinogens that have the capacity to 
accumulate in cells and generate and propagate the production of endogenous ROS. The results 
of this study help elucidate the unique properties of iqmik and stress the necessity to understand 
the biological response to iqmik use through future studies.
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Table 1.1 The pH for artificial saliva extracts of iqmik, air-cured tobacco, punk ash and saliva 
extracts diluted 1:1 in cell culture media.
Saliva Extract pH Undiluted pH Diluted
Punk Ash 10.59 ± 0.01 9.59 ± 0.08
Tobacco 6.32 ± 0.02 6.86 ± 0.09
Iqm ik 10.02 ± 0.05 9.03 ± 0.08
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Table 1.2 Artificial saliva extraction efficiency.
Co Cd Ni
Punk Ash 1.7% 0.0% 1.7%
Tobacco 17.3% 26.0% 2.4%
Iqm ik 10.3% 3.6% 5.9%
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Figure 1.1 The concentration of Co, Cd and Ni in iqmik and its components. Iqmik, air-cured 
tobacco and punk ash (1g) samples were processed and digested as detailed in the ‘Material and 
Methods’ to determine the concentration of Co, Cd and Ni in each sample. Each bar is 
representative of mean ± SEM of triplicate samples. Statistical significance is indicated between 
means by horizontal line and *P < 0.05; ** P < 0.01; *** P  < 0.001.
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Figure 1.2 The concentration of Co, Cd and Ni in iqmik, air-cured tobacco and punk ash artificial 
saliva extracts. Iqmik, air-cured tobacco and punk ash (1g) samples were extracted in 25mL 
artificial human saliva as detailed in the ‘Material and Methods’ to determine the concentration 
of Co, Cd and Ni in each artificial saliva sample. Each bar is representative of mean ± SEM of 
triplicate samples. Statistical significance is indicated between means by horizontal line and *P < 
0.05; ** P < 0.01; *** P < 0.001.
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Figure 1.3 The concentration of Co, Cd and Ni accumulation in HGEP. Differentiated HGEP 
were exposed to artificial saliva, or artificial saliva extracts o f iqmik, tobacco, or punk ash 
diluted 1:1 with differentiation media for 24 hours prior to digestion as detailed in the ‘Material 
and Methods’ to determine the concentration of Co, Cd and Ni accumulation in HGEP. Each bar 
is representative of mean ± SEM of triplicate samples. Statistical significance is indicated 
between means by horizontal line and *P < 0.05; ** P < 0.01; *** P < 0.001.
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Figure 1.4 The effect of iqmik, Co, Cd and Ni on intracellular ROS levels. (A) Differentiated 
HGEP were treated H2DCFDA (15^M) for 1 hour, or PBS. HGEP were exposed to artificial 
saliva, artificial saliva extracts of iqmik, air-cured tobacco or punk ash diluted 1:1 with 
differentiation media for 3 hours as detailed in the ‘Material and Methods’ to measure ROS 
levels. (B) Differentiated HGEP were treated H2DCFDA (15^M) for 1 hour, or PBS. HGEP 
were exposed to CoCl2 (1ppm), NiCl2 (1ppm) or CdCl2 (1ppm) in artificial saliva diluted 1:1 
with differentiation media for 3 hours as detailed in the ‘Material and methods’ to measure ROS 
levels. Each bar is representative o f mean ± SEM of triplicate samples. Statistical significance is 
indicated between means by horizontal line and *P < 0.05; ** P < 0.01; *** P < 0.001.
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C hapter 2. Iqm ik, an Alaskan smokeless tobacco m ixture, alters NF-k B m ediated
2
inflam m atory and cellular stress response genes 
A bstract
Objectives: Smokeless tobacco (SLT) users have a 4 - 6 times higher risk for developing oral 
cancer than non-users and risk of oral cancer increases with years of use. The mechanism by 
which SLT, especially iqmik, triggers an inflammatory stress response is poorly defined. The 
purpose of this study was to establish an in vitro differentiated human gingival epithelial primary 
(HGEP) cell system, and to investigate the impact of tobacco and iqmik exposure on the 
expression of NF-k B signaling target genes in these differentiated human oral epithelial cells. 
Material and methods: Differentiation was determined by protein and gene expression of keratin 
10 and keratin 14. COX2 and NF-k B signaling target gene expression was measured a using 
qPCR and analyzed using RT2 PCR Array Data.
Results: Iqmik induced 1.9 fold greater COX2 gene expression than tobacco exposure alone. 
Iqmik treatment altered gene expression of 41 of the NF-k B signaling target genes compared to 
the saliva treatment. Genes altered by iqmik treatment are involved in evading and inducing 
apoptosis, angiogenesis, blocking differentiation, proliferation, coagulation cascade and 
inflammation.
Conclusion: Iqmik induces a distinct profile of redox-regulated gene expression compared to 
tobacco leaf alone, including many of the key NF-k B dependent inflammatory and 
proangiogenic cytokines including IL-1, IL-6, IL-8, GM-CSF and members of the TNF family.
2 Dwyer, G.K. and Knall, C. (2015). Iqmik, an Alaskan smokeless tobacco mixture, alters NF-k B 
mediated inflammatory and cellular stress response genes. Submitted to the journal Oral 
Oncology.
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2.1 Introduction
Prolonged use of smokeless tobacco (SLT) has been reported to have significant adverse effects 
on human health. Tobacco use is a significant risk factor for oral disease specifically oral 
mucosal lesions, periodontal disease and oral cancers. Oral mucosal lesions, including 
leukoplakia, submucous fibrosis and oral lichen planus are common in SLT users and can 
develop with limited use [1]. Leukoplakia is the most prevalent epithelial precancerous lesion 
and has a malignant transformation rate of 12.1%, worldwide [2, 3]. Head and neck squamous 
cell carcinoma (HNSCC) is commonly preceded by the appearance of oral mucosal lesions. The 
International Agency for Research on Cancer (IARC) recently concluded that there is a causal 
association between SLT and oral cancer [4]. SLT users have a 4 - 6 times higher risk for 
developing oral cancer than non-users and risk of oral cancer increases with years of use. 
Tobacco and alcohol are identified as important etiological agents in the development of 
HNSCC. [5-7]. HNSCC is a significant problem because of the poor 5-year survival rate and 
functional defects associated with treatments [2]. HNSCC, the sixth most common cancer in the 
world, is especially prevalent in Alaska [8-10].
SLT is used by 6% of all adult Alaskans compared to the national average of only 5% of all 
adults. The percentage of Alaska Native people who use SLT is 4 times that of non-Native 
Alaskans and 45 times higher for Alaska Native women than non-Native women. The use of 
SLT is concentrated in Southwest Alaska where 32% of all adult Alaska Native people use SLT. 
Out of all adult Alaska Native people who use SLT, 35% use only iqmik, a unique Alaska- 
specific form [11]. Iqmik is a combination of tobacco leaves mixed with Phellinus igniarius 
(punk fungus). The fungus is collected, air-dried and then burned to fine white ash which is 
mixed with the air-cure leaf tobacco by mastication [12, 13]. However, very little is known about
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the health effects of iqmik exposure and prevalence of HNSCC correlated to the specific use of 
iqmik.
The addition of ash not only increases the amount of bioavailable nicotine from the tobacco 
for absorption into the oral mucosa, but also is a source of higher levels of pro-inflammatory 
toxic metals than cured leaf tobacco. More cobalt (Co), nickel (Ni) and cadmium (Cd) could be 
extracted from mixtures of ash and leaf tobacco than from leaf tobacco alone when extracting 
with artificial human saliva [14]. Co and Ni engage in redox reactions, and induce the production 
of reactive oxygen species (ROS). Cd depletes antioxidant enzymes by binding their sulfhydryl 
groups, allowing ROS production to go unchecked. Exposure to saliva extracts of iqmik induces 
significantly more ROS than those of tobacco leaf (Dwyer and Knall, unpublished data). High 
levels of ROS activate redox-regulated transcription factors such as nuclear factor kB (NF-k B), 
which is the major inflammatory transcription factor, and plays a central role in many stress 
responses [15, 16].
NF-k B regulates the transcription of various genes involved in inflammation, proliferation and 
cell survival. Overexpression of NF-k B may be involved in the development and progression of 
malignant processes in multiple sites, including the oral cavity [2]. NF-k B can be activated in 
oral epithelial cells exposed to khaini, a tobacco and slaked lime mixture, with a very alkaline 
pH, used in India [17-19]. The NF-k B regulated gene cyclooxygenase-2 (COX2) shows 
increased expression in oral epithelial cells exposed to an extract of khaini [18-21]. COX2 is a 
crucial enzyme in the biosynthesis of prostaglandins and is expressed in high levels in many 
carcinomas including HNSCC [22]. Aberrant expression and activity of COX2 are causally 
involved in tumor promotion and progression [23]. The activation of NF-k B and the increased 
expression of NF-kB regulated genes such as COX2 by iqmik are unknown.
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The epithelium of the oral cavity is composed of keratinocytes that are continuously renewed 
from the basal cell layer. The masticatory mucosa of the gingiva and hard palate undergo 
keratinization when differentiating [23, 24]. The intermediate filaments of the epithelial cell 
cytoskeleton are composed of keratin proteins whose specific isotype expression changes as a 
consequence of differentiation. Keratin 14 is expressed in cells of the basal layer, but upon 
differentiation, Keratin 10 is expressed in the gingiva [24]. Disruption of terminal keratinocyte 
differentiation seems to be a mechanism by which COX2 promotes epithelial tumor formation
[23].
The purpose of this study was to establish an in vitro differentiated human gingival epithelial 
primary (HGEP) cell system, and to investigate the impact of tobacco and iqmik exposure on the 
expression of NF-k B signaling target genes in these differentiated human oral epithelial cells.
2.2 M aterials and methods
2.2.1 Iqmik, punk ash and air-cured tobacco preparation, extraction and p H  determination 
Following community practice for iqmik preparation without mastication (Renner, Personal 
Communication), air-cured whole leaf tobacco was cut into small homogeneous pieces using a 
coffee bean grinder. Punk fungus was sawed into pieces weighing 300g or less, placed into a 
metal coffee can and ashed on a hot plate set on high. Punk ash and air-cured tobacco leaf were 
each weighed out to 1g for extracts. Iqmik extracts were prepared by combining 0.5g punk ash 
and 0.5g tobacco. Artificial human saliva was prepared with 5.3mM KSCN, 15mM NaHCO3, 
20mM KCl, 1.4mM NaH2PO4, 0.1g/L CH4N2O (urea), and 0.1mg/L a-amylase. Each sample 
(1g) was extracted in 25mL artificial human saliva. Each sample was inverted 7 times and 
incubated for 30 minutes at 37°C and 5% CO2. Samples were centrifuged for 10 minutes at 2000 
x g, the supernatant was removed from the solid phase, and filter sterilized [14]. For pH
40
determination, prepared extracts in triplicate were either undiluted or diluted 1:1 with CnT-32 
Oral Epithelium Medium (CELLnTEC Advanced Cell Systems AG, Bern, Switzerland) 
containing CaCl2 (1mM) and measured at room temperature with a Oakton pH meter (Oakton 
Instruments, Vernon Hills, IL) equipped with a Orion probe (Thermo Scientific, Waltham, MA).
2.2.2 Cell culture and differentiation
Primary human gingival epithelial cells (HGEP) (CELLnTEC) were cultured for use in the 
experiments. Cultures were maintained at a seeding density of 4.0 x 103 cells per cm2 in CnT-24 
PCT Oral Epithelium Medium (CELLnTEC). For cultures to be exposed, cells were grown for 
approximately 6-8 days in CnT-24 PCT Oral Epithelium Medium until one day prior to 
confluency at which time the medium were changed to CnT-32 Oral Epithelium Medium 
(CELLnTEC). Cultures were grown for an additional 24 hours and then induced to differentiate 
in CnT-32 containing CaCl2 (1mM) (differentiation media) per manufactures directions. Cells to 
be exposed were cultured in differentiation media for 96hrs before all exposures.
2.2.3 Cell viability
The Live/Dead Cell Assay (Molecular Probes, Life Technologies, Carlsbad, CA) was used to 
determine viability of exposed differentiated HGEP. Differentiated HGEP were exposed to 
artificial saliva, artificial saliva extracts of iqmik, air-cured tobacco or punk ash and extracts 
diluted 1:1 in differentiation media for 24 hours. Treated differentiated HGEP were then 
incubated with, calcein AM (1pM), and ethidium homodimer-1 (2pM), live and dead dyes, 
respectively, for 30 minutes. Control differentiated HGEP were incubated in differentiation 
media (live control), or methanol (70%) (dead control) for 45 minutes. Cell viability was 
quantified as fluorescence intensity using a fluorescence microplate reader (Molecular Devices, 
Sunnyvale, CA).
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2.2.4 Gene expression during differentiation
Keratin 10 (KRT10), Keratin 14 (KRT14) and COX2 (PTSG2) gene expression was assayed in 
HGEP during the differentiation process at 4 time points, just prior to switching from CnT-24 
Oral Epithelium Medium to CnT-32 Oral Epithelium Medium (undifferentiated state), and then 
24hrs, 48hrs, and 96hrs after the addition of differentiation media. RNA was isolated using the 
TRIzol protocol (Invitrogen-Life Technologies, Carlsbad, CA). RNA concentrations were 
determined using a spectrophotometer. Complimentary DNA was synthesized using the 
SuperScript II Reverse Transcriptase protocol (Invitrogen-Life Technologies). PTGS2, KRT10 
and KRT14 primers (Qiagen, Valencia, CA) were used to analyze the gene expression of COX2, 
KRT10 and KRT14. P actin (ACTB), glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and 
TATA-binding protein (TBP) primers (Qiagen) were used to amplify these housekeeping genes 
to normalize gene expression. The gene expression was quantified with quantitative polymerase 
chain reaction (qPCR) following the Fast SYBR Green Master Mix protocol (Invitrogen-Life 
Technologies) using the StepOnePlus (Applied Biosystems, Grant Island, NY) real-time PCR 
instrument programmed as follows, 10 minute, 95oC cycle followed by 40 cycles of alternating 
15 sec, 95oC denaturation and 1 minute, 60oC annealing/extension.
2.2.5 Preparation o f  cell lysates and protein assay
Cells were grown to confluence in 6 well tissue culture plates, washed with PBS and lysed with 
100^L Mg lysis buffer (25mM Hepes pH 7.5, 150mM NaCl, 1% Igepal CA-630, 0.25% NaDOC, 
10% glycerol, 25mM NaF, 10mM MgCl2, 1mM EDTA, 1mM Na3VO4, 10p,g/mL lupeptin, 
10mg/mL aprotinin) on ice. A cleared lysate was collected following centrifugation at 4°C, 
14,000Xg for 10 min. Protein concentrations in cleared cell lysates were determined using RC 
DC Protein Assay (Bio-Rad, Hercules, CA) according to manufacturer’s instructions, and the
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absorbance determined using a DU 730 Life Science UV/Vis Spectrophotometer (Beckman 
Coulter, Indianapolis, IN).
2.2.6 SDS-PAGE and western blot analysis
Whole cell lysates were diluted with 5X SDS sample buffer for 1 mg/mL total protein. Samples 
(1 mg/mL protein) were separated by SDS-PAGE and transferred on to Immobilon-FL PVDF 
membranes (EMD Millipore, Bellerica, MA). Membranes were blocked with 1X TBS, 0.1% 
Tween-20 (TBST) containing 5% nonfat dry milk (blocking buffer) for 1hr, and then incubated 
overnight at 4°C in TBST containing 5% BSA and antibody against keratin 14 (1:20,000,
Abcam, Cambridge, MA), keratin 10 (1: 50,000, Abcam) or P-actin (1:1000, Thermo Scientific, 
Waltham, MA) as loading control. Membranes were washed 3 times for 5 min each in TBST and 
incubated with secondary anti-rabbit IgG HRP-linked antibody (1:2000, Cell Signaling 
Technology, Beverly, MA) in blocking buffer. Membranes were washed in TBST 3 times for 5 
min each and protein bands visualized with SuperSignal West Femto maximum sensitivity 
substrate (Life Technologies) using FlourChem HD2 and AlphaView FlourChem HD2 software 
(Proteinsimple, San Jose, CA).
2.2.7 Gene expression following exposure
Differentiated HGEP were exposed for 4hr to artificial saliva, or saliva extracts of iqmik or air- 
cured tobacco (40 mg/ml w/v) diluted 1:1 in differentiation media. Following exposure, COX2 
gene expression was assayed as described for gene expression during differentiation.
To determine alterations in NF-k B regulated gene expression in differentiated HGEP as a 
consequence of exposure to artificial saliva alone or artificial saliva extracts of iqmik or tobacco 
diluted 1:1 with differentiation media, NF-k B Signaling Targets RT2 Profiler PCR Arrays 
(Qiagen) were used following manufacturer’s instructions. Differentiated HGEP were exposed
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for 4hr to artificial saliva or diluted saliva extracts of iqmik or tobacco with each exposure being 
performed in three independent experiments. Following the exposure, RNA was isolated using 
the RNeasy Mini Kit (Qiagen) following manufacturer’s instructions. RNA concentrations were 
determined using a spectrophotometer. The first strand cDNA was synthesized using the RT2 
First Strand Kit (Qiagen), which contains a proprietary buffer to eliminate any residual genomic 
DNA contamination in RNA samples. The cDNA was mixed with the RTC SYBR Green 
Mastermix and aliquoted into the 96-well plate of the RT2 Profiler PCR Array, containing PCR 
primer pairs for a total of 84 genes to be screened. Amplification was performed using the 
StepOnePlus (Applied Biosystems) programmed for a 10 minute, 95oC cycle followed by 40 
cycles of alternating 15 sec, 95oC denaturation and 1 minute, 60oC annealing/extension. The 
threshold cycle (CT) was calculated using the StepOnePlus software following RT2 Profiler PCR 
Array guidelines. Dissociation curve analysis on each well was performed to verify PCR 
specificity.
2.2.8 RT2 Profiler PCR Array data analysis
Data was analyzed using RT2 Profiler PCR Array Data Analysis freeware (Qiagen). The 
housekeeping genes, ACTB, GAPDH and RPLP0 (Ribosomal protein, large, P0), included in the 
arrays, were selected for normalization of data. Genomic DNA controls were negative and 
controls for reverse-transcription efficiency and the efficiency of the PCR reaction were within 
manufacturer defined parameters (data not shown). The relative expression of individual genes 
tested in the RT2 Profiler PCR Array was determined using individual well CT values reported 
by the StepOnePlus and the AACT method after normalization. Genes were reported as altered 
using the method of Huggins et al. 2008 [25] which uses both fold change of >1.3 andp  < 0.2 to 
establish biologically relevant changes in gene expression. Altered genes were mapped to cancer
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and inflammatory pathways using REACTOME an open-source, open access, manually curated 
and peer-reviewed pathway database [26, 27].
2.2.9 Statistical analysis
All reported results represent the mean ± SEM of data obtained in three independent 
experiments. Statistical analysis was performed with the one-way ANOVA and Tukey’s HSD 
post hoc tests. P  < 0.05 was considered statistically significant.
2.3 Results
2.3.1 HGEP differentiation determination
Keratin 10 and Keratin 14 gene and protein expression were determined at 3 time points during 
the differentiation process. Keratin 14 was identified in HGEP just prior to the initiation of the 
differentiation process (Figure 2.1A, 2.1C and 2.1D). Cultures were tested for expression of 
Keratin 10 and Keratin 14 at 24, 48 and 96 hours after the addition of differentiation media. 
Keratin 14 gene and protein expression varied minimally during the differentiation process 
(Figure 2.1A, 2.1C and 2.1D). In sharp contrast, Keratin 10 gene and protein expression 
increased significantly during HGEP differentiation and continued to increase through the 96 
hour time point, with a significant increase in expression at 24 hours (p < 0.014, gene), 48 hours 
(p < 0.0023, gene) and 96 hours (p < 0.0009, gene, p  < 0.0001, protien) compared to 
undifferentiated HGEP (Figure 2.1B, 2.1C and 2.1D).
2.3.2 COX2 gene expression during HGEP differentiation
COX2 gene expression was measured in undifferentiated HGEP and at 3 time points, 24, 48 and 
96 hours, during the differentiation process. COX2 gene expression was detected in HGEP just 
prior to the initiation of the differentiation process (Figure 2.2). As one would predict, the 
expression of COX2, which is associated with mesenchymal traits, decreased upon
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differentiation of the epithelial cells (Figure 2.2). After 24 hours in differentiation media, COX2 
gene expression had decreased by approximately 9 fold, and maintained the reduced expression 
through the 96 hour time point with differentiation media.
2.3.3 Cell viability o f  exposed differentiated HGEP
To determine the effect on cell viability of artificial saliva, and artificial saliva extracts of 
tobacco, punk ash or iqmik, with or without dilution in differentiation media, differentiated 
HGEP were exposed for 24 hours to these various treatments. Extracts of air-cured tobacco (p <
0.0001) and artificial saliva (p < 0.0001) diluted 1:1 in differentiation media were significantly 
less cytotoxic than pure extract (Figure 2.3). HGEP treated with artificial saliva extracts of iqmik 
(p < 0.0001), air-cured tobacco (p < 0.0001) and saliva alone (p < 0.0001) diluted 1:1 in 
differentiation media exhibited significantly less cytotoxicity than the control dead samples 
(Figure 2.3).
2.3.4 COX2 gene expression in exposed differentiated HGEP
Differentiated HGEP were exposed for 4 hours to artificial saliva or saliva extracts of iqmik or 
tobacco, and COX2 gene expression was measured by qPCR. Short-term exposure to iqmik 
resulted in an up-regulation of COX2 gene expression (Figure 2.4). Iqmik induced 1.9 fold 
greater COX2 gene expression than tobacco exposure, although not statistically significant, and a 
significantly greater up-regulation of COX2 gene expression than the media control (p < 0.0001).
2.3.5 NF-k B signaling target gene expression
NF-k B signaling target gene expression was measured with RT2 Profiler PCR Arrays, containing 
PCR primer pairs for a total of 84 genes. Iqmik treatment altered gene expression of 41 of the 
NF-k B signaling target genes compared to the saliva treatment alone using the parameters 
defined in Huggins et al. (2008) (Table 2.1). Genes altered by iqmik treatment are involved in
46
evading and inducing apoptosis, angiogenesis, blocking differentiation, proliferation, coagulation 
cascade and inflammation. Tobacco treatment altered 31 of the NF-k B signaling target genes 
compared to the saliva treatment alone (Table 2.2). Many of the iqmik altered genes mapped to 
cancer and inflammatory pathways in the REACTOME, a peer-reviewed database (Table 2.3). 
The cancer-associated pathways include sustained angiogenesis, coagulation cascade, 
proliferation, blocking differentiation and pro-apoptosis/anti-apoptosis. The inflammation- 
associated pathways include TNF family, IL-1 family, interferons, cell recruitment, 
hematopoietins, coagulation cascade and IL-6 signaling.
2.4 Discussion
The oral epithelium basal layer includes cells with a self-renewing capacity. These cells are 
responsible for renewing the epithelium lining and regenerate rapidly when damaged. These cells 
differentiate as they move through the layers of epithelium and become keratinocytes in the 
gingival area. HNSCC likely arises from an accumulation of mutations within the renewing cell 
population of the basal layer or from differentiated cells that have regained the capacity to self- 
renew [28].
COX2 is not expressed under normal physiologic conditions, but is widely overexpressed in 
pathophysiologic conditions, such as cancer [29, 30]. COX2 activation is an early event during 
carcinogenesis. COX2 overexpression is evident in oral mucosal lesions with an increasing level 
of COX2 expressed from hyperplasia to dysplasia with the highest levels reported in HNSCC
[31]. The overexpression of COX2 alters cell adhesion, alters the response to signals from 
growth regulators and inhibits apoptosis [32]. Products of COX2 enzyme activity, the 
prostaglandins, activate nuclear hormone receptors that are responsible for intracellular levels of 
calcium and increase cellular proliferations rates [29]. Prostaglandins also promote angiogenesis
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and inhibit immune surveillance [29, 33]. COX2 deficiency has been demonstrated to protect 
against the formation of epithelial tumors [23, 34]. The reduced tumor formation is in response 
to premature terminal differentiation in keratinocytes. Keratins 1 and 10, indicators of 
commitment to differentiate, are both expressed in basal keratinocytes in COX-2 deficient mice
[34].
NF-k B signaling is suggested to play an important role in the early stages of head and neck 
cancer. Protein levels of NF-kB gradually increase from premalignant lesions to invasive cancer
[28]. NF-kB activation can stimulate STAT3, another key transcription factor in HNSCC, 
through IL-6 signaling. HNSCC has many aberrantly activated, interrelated signaling pathways
[35].
Studies have found that long-term SLT exposure can cause disturbances in the differentiation 
process of the oral epithelium. Three-dimensional epithelial cultures exposed to long-term 
treatments of Swedish snuff showed weaker expression of keratin 10 than the control samples 
that expressed keratin 10 in the upper two thirds of the epithelium [36, 37]. In our study we 
demonstrated differentiation of the HGEP prior to treatment by the increasing expression of 
keratin 10. A future study should investigate long-term iqmik treatments effect on keratinization 
markers such as keratin 10 and involucrin [36].
High levels of IL-1a and P have been observed at the SLT placement site of habitual users, 
indicating an inflammatory response and aberrant epithelial proliferation [38]. Studies that 
utilized human volunteers demonstrated development of SLT lesions in over half the volunteers 
by day 7, as well as, a significant increase in IL-1a and prostaglandin E2, a downstream product 
of COX2 enzymatic activity [37-39]. Animal studies have demonstrated an up-regulation of 
COX2 at the site of SLT application [21]. In our experiments, short-term exposure to iqmik
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resulted in what appears to be an up-regulation of COX2 expression greater than tobacco 
exposure alone, but is not statistically significant.
Prominent features of oral cancer include alterations to host immunity, inflammation, 
angiogenesis and metabolism and are associated with increased tumor growth, metastasis and 
decreased survival rates. Tumor development requires proinflammatory, proangiogenesis and 
immunoregulatory signaling. NF-kB is an early response gene that is elevated by tobacco use 
and chronic inflammatory conditions. The overexpression of NF-k B correlates with the 
overexpression of proinflammatory, proangiogenic and anti-apoptotic signaling which are 
prevalent in HNSCC [40].
Iqmik exposure altered the gene expression of 41 of the tested NF-k B signaling target genes 
(Table 2.1) compared to the saliva treatment alone as defined by the parameters of Huggins et al.
[25], which has been found to identify more biologically meaningful sets of altered genes than p- 
value alone or more strict fold-change and p-value cut-offs [41]. Genes altered by iqmik 
exposure are involved in evading and inducing apoptosis, angiogenesis, blocking differentiation, 
proliferation, coagulation cascade and inflammation. Tobacco exposure altered 31 of the test 
genes (Table 2.2) compared to the saliva treatment alone. Iqmik treatments had a unique NF-k B 
signaling target gene expression profile, 9 genes altered by both iqmik exposure and tobacco 
exposure were upregulated by iqmik, but down regulated by tobacco exposure, and 24 of the 
altered genes were more significantly altered by iqmik than by tobacco, based on the Huggins et 
al. [25] significance parameters.
2.5 Conclusion
Although Iqmik is perceived as a safer alternative to other tobacco products [42], it induces more 
cancer associated genes than tobacco alone including many of the key NF-KB-dependent
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inflammatory and proangiogenic cytokines, such as, IL-1, IL-6, IL-8, GM-CSF and members of 
the TNF family. Tobacco use is a significant risk factor for oral disease, specifically oral 
mucosal lesions, periodontal disease and oral cancers, such as HNSCC, which is especially 
prevalent in Alaska. The findings reported herein make iqmik a unique health hazard compared 
to other tobacco products.
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Table 2.1 Iqmik altered NF-k B signaling target genes.
Gene________________________Name_____________________Fold Regulation p-value
EGR2 Early growth response 2 67.0 0.17
CSF2 Colony stimulating factor 2 46.6 0.08
NCOA3 Nuclear receptor coactivator 3 13.5 0.13
CCL2 Chemokine (C-C motif) ligand 2 12.6 0.22
SNAP25 Synaptosomal-associated protein, 25kDa 12.1 0.06
MYC V -myc myelocytomatosis viral oncogene homolog 11.6 0.17
IL1R2 Interleukin 1 receptor, type II 10.7 0.07
IL8 Interleukin 8 10.5 0.19
IL1A Interleukin 1, alpha 8.2 0.15
NR4A2 Nuclear receptor subfamily 4, group A, member 2 8.0 0.15
SELE Selectin E 7.2 0.11
LTA Lymphotoxin alpha (TNF superfamily, member 1) 7.0 0.19
PTGS2 Prostaglandin-endoperoxide synthase 2 
(prostaglandin G/H synthase and cyclooxygenase)
6.7 0.02
CSF3 Colony stimulating factor 3 6.0 0.21
IL1B Interleukin 1, beta 6.0 0.08
IL6 Interleukin 6 (interferon, beta 2) 5.3 0.02
CD83 CD83 molecule 4.7 0.02
CCL22 Chemokine (C-C motif) ligand 22 4.6 0.18
REL V -rel reticuloendotheliosis viral oncogene homolog 4.4 0.08
IFNB1 Interferon, beta 1, fibroblast 4.2 0.15
IL1RN Interleukin 1 receptor antagonist 4.2 0.22
BIRC2 Baculoviral IAP repeat containing 2 3.4 0.01
F3 Coagulation factor III (thromboplastin, tissue factor) 2.9 0.13
CDKN1A Cyclin-dependent kinase inhibitor 1A (p21, Cip1) 2.8 0.11
XIAP X-linked inhibitor of apoptosis 2.8 0.07
EGFR Epidermal growth factor receptor 2.7 0.03
CXCL2 Chemokine (C-X-C motif) ligand 2 2.7 0.04
IL15 Interleukin 15 2.6 0.03
NQO1 NAD(P)H dehydrogenase, quinone 1 2.6 0.03
AGT Angiotensinogen 2.3 0.14
CCND1 Cyclin D1 2.1 0.23
TNFSF10 Tumor necrosis factor (ligand) superfamily, member 
10
Nuclear factor of kappa light polypeptide 
gene enhancer in B-cells inhibitor, alpha
2.1 0.16
NFKBIA 2.1 0.09
ALDH3A2 Aldehyde dehydrogenase 3 family, member A2 1.7 0.17
CSF1 Colony stimulating factor 1 1.7 0.19
IRF1 Interferon regulatory factor 1 1.7 0.15
STAT3 Signal transducer and activator of transcription 3 1.6 0.07
PLAU Plasminogen activator, urokinase 1.6 0.16
PDGFB Platelet-derived growth factor beta polypeptide -2.0 0.15
ADM Adrenomedullin -2.6 0.02
TNFRSF1B Tumor necrosis factor receptor superfamily, member -4.9 0.22
1B
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Table 2.2 Tobacco altered NF-k B signaling target genes.
Gene Name Fold Regulation ^-value
CSF2 Colony stimulating factor 2 8.2 0.13
IL1B Interleukin 1, beta 6.7 0.00
IL1A Interleukin 1, alpha 6.5 0.01
PTGS2 Prostaglandin-endoperoxide synthase 2 
(prostaglandin G/H synthase and cyclooxygenase)
5.4 0.05
CSF3 Colony stimulating factor 3 5.0 0.01
NR4A2 Nuclear receptor subfamily 4, group A, member 2 4.7 0.06
NCOA3 Nuclear receptor coactivator 3 4.0 0.00
CSF2RB Colony stimulating factor 2 receptor, beta, low- 
affinity
3.5 0.17
IL8 Interleukin 8 3.5 0.08
IL6 Interleukin 6 (interferon, beta 2) 3.1 0.21
BCL2A1 BCL2-related protein A1 3.0 0.19
REL V-rel reticuloendotheliosis viral oncogene homolog 2.9 0.03
EGFR Epidermal growth factor receptor 2.7 0.01
SNAP25 Synaptosomal-associated protein, 25kDa 2.6 0.20
PLAU Plasminogen activator, urokinase 2.4 0.06
CCL22 Chemokine (C-C motif) ligand 22 2.3 0.08
NFKBIA Nuclear factor of kappa light polypeptide 
gene enhancer in B-cells inhibitor, alpha
2.3 0.03
FASLG Fas ligand (TNF superfamily, member 6) 2.2 0.07
MYC V-myc myelocytomatosis viral oncogene homolog 2.0 0.23
BIRC2 Baculoviral IAP repeat containing 2 1.9 0.01
XIAP X-linked inhibitor of apoptosis 1.7 0.16
NQO1 NAD(P)H dehydrogenase, quinone 1 1.6 0.09
IL15 Interleukin 15 1.5 0.23
RELA V-rel reticuloendotheliosis viral oncogene homolog 
A
Nuclear factor of kappa light polypeptide 
gene enhancer in B-cells 1
1.5 0.11
NFKB1 1.4 0.24
IFNB1 Interferon, beta 1, fibroblast -2.4 0.19
CXCL1 Chemokine (C-X-C motif) ligand 1 
(melanoma growth stimulating activity, alpha)
-2.7 0.14
ADM Adrenomedullin -2.8 0.00
TNFRSF1B
Tumor necrosis factor receptor superfamily, member 
1B
-4.4 0.17
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Table 2.3 Iqmik altered genes in cancer and inflammatory pathways.
Iqmik Altered Inflammatory Genes Iqmik Altered Genes in Cancers Pathways
Coagulation Hematopoietins Coagulation Proliferation Pro-apoptotic
Cascade IL6 Cascade IKBa TRAIL/TNFSF10
F3 CSF1, 2, 3 F3 NFk B IL1
F8 IL15 F8 c-Myc TNFR1
PLAU
Interferons
IL6 Signaling
AGT
PLAU
Sustained
Cyclin D1
p21
NCOA3
EGFR
LTA
AGT
IFNB1 IKBa Angiogenesis Anti-apoptotic
TNF Family
LTA
TNFRSF1B
NFk B PDGFB IAPs
IL6 IKBa PDGFBAGT BCL-xLSTAT3 NFk B IL15
TRAIL/TNFsf10 Cell Recruitment COX2 Blocking IKBa
IL8
SELE
CXCL2
STAT3 Differentiation NFk B
IL-1 Family IL8 IL6
IL1A & IL1B c-Myc C-Myc
IL1R2 CCL2
CCL22
EGFR CSF1, 2, 3
IL1RN/RA NCOA3
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Figure 2.1 Keratin 10 and 14 gene and protein expression in HGEP differentiation. Keratin 14 
(A) and keratin 10 gene (B) and protein (C) expression was determined by qPCR and western 
blot of keratin 14 (52 kDa), keratin 10 (60 kDa) and P-actin (42 kDa) (D), as described in 
Materials and Methods during HGEP differentiation, just prior to starting, and then at 24, 48, and 
96hrs after the addition of differentiation media. Gene data are representative of triplicate 
samples and are expressed as 2"ACT. Data are representative o f mean ± SEM. Significance 
represents comparison to undifferentiated (UNDIF) control for all data, *p < 0.05; ** p  < 0.01;
*** p  < 0.001.
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Figure 2.2 COX2 gene expression during HGEP differentiation. COX2 gene expression was 
determined by qPCR during HGEP differentiation just prior to starting, and then at 24, 48, and 
96hrs after the addition of differentiation media as detailed in Material and methods. Data are 
representative of triplicate samples and are expressed as 2-ACT. Data are representative of mean ± 
SEM. Data are not significant, but represent a trend in gene expression.
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Figure 2.3 Cell viability following saliva extract exposure. Cell viability was measured with the 
Live/Dead Cell Assay after differentiated HGEP were exposed for 24hrs to artificial saliva, 
artificial saliva extracts o f iqmik, air-cured tobacco or punk ash or extracts diluted 1:1 in 
differentiation media as detailed in Material and methods. C represents control. Data are 
representative of mean ± SEM of triplicate samples.
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Figure 2.4 COX2 gene expression in differentiated HGEP exposed to diluted iqmik and tobacco 
saliva extracts. COX2 gene expression was determined by qPCR after differentiated HGEP were 
exposed for 4hrs to the indicated saliva extracts as detailed in Material and methods. Data are 
representative of triplicate samples and are expressed as 2"ACT. Data are representative of mean ± 
SEM. Significance represents comparison to media control, *p < 0.05; ** p  < 0.01; ***
0.001.
p  <
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C hapter 3. Biom arkers for iqmik smokeless tobacco use: future research directions 
A bstract
Alaska Natives have an oral cancer incidence rate of 16.0 cases per 100,000 per year. The 
incidence of oral cancer is estimated to be rising annually by 2.6% in Alaska, and for Alaska 
Natives the incidence is rising by 6.5% annually. Nearly half of patients diagnosed with oral 
cancers have already developed metastases prior to their diagnosis. This stresses the need for 
early detection of pre-malignant oral lesions to improve patients’ survival. Several diagnostic 
methods are currently in development for earlier diagnosis of oral cancers, including saliva 
biomarkers. The advantage of saliva biomarker analysis is the easy and noninvasive collection 
procedure. This article proposes a case-control study to determine biomarkers for oral cancer in 
tobacco users in Alaska and to develop an accurate method for earlier detection of oral cancer by 
testing the level of inflammatory cytokines in saliva samples. This proposed pilot study will 
provide a foundation for future tobacco and oral cancer biomarker research in Alaska focused on 
addressing health concerns related to tobacco use in Alaska Native peoples.
3
3 Dwyer, G.K. and Knall, C. Biomarkers for iqmik smokeless tobacco use: future research 
directions. Prepared for submission in the Hypotheses/Commentaries section in the journal 
Cancer Epidemiology Biomarkers & Prevention.
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3.1 Introduction
Head and neck cancers are the sixth most common cancer in the world and are especially 
prevalent in Alaska (1-3). Oral squamous cell carcinomas (OSCC), which arise from the 
epithelium lining of the oral cavity, make up more than 90% of all oral cancers (4). Alaska 
Natives have an oral cancer, age-adjusted, incidence rate of 16.0 cases per 100,000 per year 
compared to 10.8 cases per 100,000 per year for non-Natives with an average of 71 cases per 
year in Alaska. The incidence of oral cancer is estimated to be rising annually by 2.6% in Alaska 
and by 6.5% among Alaska Native peoples. Among Alaska Native people the mortality rate from 
oral cancer is 6.1 cases per 100,000 per year which is more than twice that at of Non-Native 
Alaskans (5).
Tobacco and alcohol are identified as important etiological agents in the development of 
OSCC. (6-9). Smokeless tobacco (SLT) users have a 4 - 6 times higher risk for developing oral 
cancer than non-users and risk of oral cancer increases with years of use. The likelihood of 
developing oral cancer is related to the amount of tobacco products used in a dose-response 
manner (10). SLT is used by 6% of all adult Alaskans compared to the national average of only 
5% of all adults. The percentage of Alaska Natives who use SLT is 4 times that of non-Native 
Alaskans. The use of SLT is concentrated in Southwest Alaska where 32% of all adult Alaska 
Natives use SLT. Out of all adult Alaska Natives who use SLT, 35% use only iqmik, a form of 
SLT unique to Alaska (11).
The development of oral cancer consists of several stages of oral premalignant lesions with 
varying degrees of dysplasia. These oral lesions precede the majority of oral cancers. A minority 
of oral cancers, approximately 30%, appear de novo from histologically normal oral epithelium 
(12, 13). Oral cancer is an aggressive cancer that commonly metastasizes to other organs, and
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nearly half of all patients diagnosed with oral cancers present with metastatic disease. HNSCC is 
a significant problem because of its poor 5-year survival rate, about 62%, and functional defects 
associated with treatments (4, 14). Early detection of oral lesions has a significant effect on 
survival rates, but a more effective method to detect oral cancers at an earlier stage is needed
(15).
The most common diagnostic tool for detecting oral cancers is by visual inspection. However, 
there is little evidence that this form of screening reduces the incidence of or mortality from oral 
cancers (10, 12). Therefore, a new method of screening, based on evidence, is needed to reduce 
the incidence and mortality associated with SLT use.
Only a small percentage of oral mucosal lesions, of which leukoplakia is the most common 
epithelial precancerous lesion, will transform into cancer with a malignant transformation rate of 
12.1%, world-wide (16). Identification of true preneoplastic changes in the oral cavity would 
benefit from molecular and biochemical detection methods. A practical application of these 
markers, implemented in the clinic, has the potential to provide a more accurate detection of oral 
lesions which will undergo malignant transformation (12).
Several diagnostic methods are currently in development for earlier diagnosis of oral cancers, 
including saliva biomarkers. A saliva based assay to test for pre-malignancy would more easily 
and accurately identify patients that will develop oral cancer. Saliva contains constituents that 
reflect the disease state of the body and particularly for the oral cavity (12, 17, 18). The 
advantage of saliva biomarker analysis is the easy and noninvasive collection procedure, 
compared to a blood draw or biopsy (4). Biomarker data should be collected that is biologically 
relevant for the population of patients being screened.
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NF-k B dependent cytokines, interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor alpha 
(TNF a) are elevated in oral squamous cell carcinoma (OSCC) tissue samples and in saliva 
samples from patients with OSCC and oral pre-malignant lesions (OPML) compared to health 
controls (19-22). Cyclooxygenase (COX) 2, another NF-k B mediated signaling target, and its 
product prostaglandin E2 (PGE2) are highly active in tobacco induced carcinogenesis of OSCC
(23).
Our laboratory has demonstrated that artificial saliva extracts of the Alaska specific SLT iqmik 
elevated NF-k B dependent proinflammatory cytokine expression (Figure 3.1) to a greater extent 
than saliva extracts of tobacco alone (Dwyer and Knall, unpublished observations). We therefore 
propose a study design to test the hypothesis that there is a difference in proinflammatory 
cytokines expressed in whole unstimulated saliva among users of tobacco types in Alaska and 
those with oral cancer.
3.2 Strategic research design
To identify biomarkers for oral cancer in tobacco users in Alaska, and to develop an accurate 
method for earlier detection of oral cancer in users of the Alaska specific SLT iqmik, a case- 
control study will be performed to test the level of inflammatory cytokines in saliva samples 
collected from participants with diagnosed oral cancer who self-report using iqmik, commercial 
SLT, cigarettes or no tobacco use. A control group of participants that are oral cancer-free will 
also be recruited into each group of tobacco use.
The case-control study is a mainstay in molecular epidemiology studies because of its ability 
to target rare diseases, and its strength in focused questionnaire information and specimen 
collection (24). The benefit of a case-control study is that it can be used to compare the disease, 
oral cancer, to healthy controls. The levels of inflammatory biomarkers can be quantitatively
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analysed between the cases and the healthy controls. Biomarker data between exogenous 
exposures, cigarettes, SLT or iqmik, will be valuable in determine the inflammatory profile 
between cases and healthy controls of each exposure group. Some of the disadvantages of a case- 
control study are that biomarker data is only collected one time and because of the incidence rate 
cannot be determined from a case-control study unless all cases from the target population are 
recruited. Case-control studies are retrospective studies and are susceptible to recall bias. The 
participants may not accurately remember the length of tobacco use. Selection bias is another 
common problem with this study design and can be a particular problem with so few cases and 
controls recruited into each group. The goal of the control group is to be representative of the 
population from which the cases are recruited. (25-27).
A longitudinal study, such as a prospective cohort study would allow for continual biomarker 
collection through the full range of oral cancer development from tobacco use. The cohort study 
design compensates for many of the biases that can arise from a case-control study and allows 
for nested case-control designs, which is more ideal for biomarker studies, allowing for 
immediate analysis after collection (28). The disadvantage of a cohort study is that it is more 
costly and the latency from tobacco exposure/use to disease development is lengthy (27).
3.3 Sample size calculation
A previous study performed by Rhodus et al., 2005 demonstrated significantly increased levels 
of cytokines IL-1, IL-6, IL-8 and TNF a  in saliva samples collected from HNSCC participants 
compared to HNSCC-free participants. A sample size of 9 participants in each group will 
provide 95% power to detect a significant difference between specific biomarker group means 
assuming a two-tailed a  = 0.05 test, if  the cytokine data has a similar distribution to the Rhodus 
et al., (20) study.
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The majority of Alaska Native peoples, from throughout Alaska, with oral cancer cases are 
diagnosed and treated in Anchorage, Alaska (Personal communication, Janet Kelly). This study 
will work with the appropriate tribal authorities to obtain tribal approval of the proposed research 
involving Alaska Native peoples, and to obtain approval from the governing Institutional Review 
Boards for research with human subjects to recruit participants in the Anchorage area.
Targeted enrolments will be focused on Alaska Natives, as they represent the vast majority of 
users of iqmik, and have higher rates of mortality for oral cancer. The goal is to recruit SLT 
(iqmik or other SLT) users, cigarette users and non-tobacco users with and without oral cancer. 
There are approximately 71 cases of oral cancers diagnosed each year in Alaska, of those 
between 20-25 cases are diagnosed at the Alaska Native Medical Center (ANMC) in Anchorage 
(Personal Communication, Matthew Olnes). Recruitment will occur at ANMC over an 18 month 
period for a total of 60 participants (Figure 3.2) accounting for an estimated 10% rate of attrition 
for a final sample size of 54 participants, 9 participants in each sub-group (oral cancer 
participants, or oral cancer-free participants into SLT, cigarette and non-user sub-groups). Oral 
cancer participants will be recruited through the Ear, Nose and Throat department at ANMC, 
where most oral cancer diagnoses occurs (Personal Communication, Matthew Olnes). Control 
participants that are age and gender matched to cases will be recruited through the Dental 
department at ANMC.
To be eligible to take part in the study, participants must meet the following inclusion criteria:
(1) be Alaska Native (2) aged 18 years or older, (3) provide written informed consent. An 
additional inclusion criterion for oral cancer participants is a primary untreated oral cancer. The 
exclusion criteria for oral cancer participants include previous chemotherapy, radiotherapy and
3.4 Participants
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previous oral surgery other than oral biopsy, and the inability to properly consent. The exclusion 
criteria for oral cancer-free control individuals included previous chemotherapy, radiotherapy, 
systemic conditions associated with immune dysfunction, and the presence of any oral mucosal 
lesions. Exclusions will include individuals that are taking any drugs that would induce 
hyposalivation and for the non-users group any tobacco use within the last 5 years. Studies have 
shown that oral cancer risk decreases by 50% after 5 years of abstinence from tobacco products
(29).
All potential participants will be provided the consent forms and given sufficient time to read 
and to address any questions that may arise before a signature is obtained, if  they wish to 
participate. Consent for banking of samples and their use in future studies will also be 
independently obtained. The participants will also be asked to consent to be contacted in the 
future regarding their biomarker results, if they wish to participate in future cessation message 
development. The participants will be given a copy of the signed consent form and the principal 
investigator will retain the original for documentation.
At the time of enrollment, an interview-based assessment will be conducted with the 
participants to assess socio-demographics, duration, amount and type of tobacco used, 
spouse/partner tobacco use, number of household tobacco users, household restrictions on 
smoking and other tobacco use, duration, amount and type of alcohol use and knowledge of 
Epstein-Barr Virus (EBV), Hepatitis C virus (HCV) or oral Human Papillomavirus (HPV) 
infection. A tobacco user is defined as a participant that has used tobacco for at least 1 year, on a 
weekly basis. Current tobacco users will be assessed for the type and amount of tobacco used 
and time of last cigarette or last SLT use. Non-tobacco users will be assessed for abstinence from 
tobacco for at least 5 years and previous use of tobacco. The assessments of tobacco use and
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other variables collected by the investigators at the time of enrollment and at sample collection 
will be entered into a database. Questionnaire data and biologic specimens will be assigned 
coded study numbers and links to personal identifiers will be kept in a password protected 
location that is separate from questionnaire data and biological specimens, and will only be 
accessible to the principal investigator.
3.5 Saliva sample analysis
Saliva samples are a minimally invasive technique that provides RNA information and key 
inflammatory markers. Saliva will be collected as described by Rhodus et al., (20). Briefly, 
subjects will expectorate all saliva into a 50 ml centrifuge tube for 5 minutes without 
swallowing. The final volume and flow rate of saliva will be determined gravimetrically. Saliva 
samples will be aliquoted appropriately for future studies, if  consented for banking, and frozen at 
-80oC. The saliva samples will be separated with centrifugation and prepared for analysis 
following the method described by Lisa Cheng et al., (21). Samples will be screened for cytokine 
expression by enzyme-linked immunosorbent assay (ELISA) (Figure 3.3) for IL-1, IL-6, IL-8, 
COX2 and TNF a (Thermo Scientific, Waltham, MA), as well as screening for EBV, HCV and 
HPV infection (Abnova, Taipei City, Taiwan) (30-32).
3.6 Statistical analysis
Nonparametric statistical tests in commercial software SPSS 10.0 (SPSS Inc., Chicago, IL) with 
significance level p < 0.05 will be used to analyze the data because of the small sample size in 
each group, which increases the potential to not fulfil the normal distribution requirement of a 
parametric test. Mann-Whitney tests will be used to compare two groups and Kruskal-Wallis test 
will be used to compare more than two groups.
Multiple linear regression modelling will be used to account for confounding variables, such
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as length of tobacco use, alcohol use, EBV, HCV and/or HPV infection, which are etiological 
agents in oral cancer development (33, 34). Multiple linear regression modelling will be used to 
compare tobacco type and oral cancer diagnosis to biomarker levels.
3.7 Feasibility measures
The number of oral cancer cases diagnosed each year in Alaska is limited, and the majority of 
iqmik users reside in Southwest Alaska. Opportunities for Alaska Natives in remote villages in 
Alaska to be diagnosed with oral cancer early are scarce. The 18-month window for patient 
recruitment may be insufficient to recruit a diverse group of participants including iqmik users. 
Therefore, data related to participant recruitment will be recorded, including the number of 
potential participants referred to, approached by the investigators and the number excluded by 
the specific criteria of the study. A recruitment rate will be calculated as the number enrolled by 
the total eligible participants. The total eligible participants will include those that satisfy the 
inclusion and exclusion criteria and are referred to the principal investigator by the medical staff 
in the departments designated for recruitment at ANMC.
3.8 Expected results
Previous studies have demonstrated a significant increase in levels of NF-k B dependent 
proinflammatory cytokines in the saliva of oral cancer patients compared to controls (20, 21). 
These same cytokines have been demonstrated to be elevated in oral preneoplastic lesions 
compared to controls, as well. With successful recruitment in this study, a significant difference 
should be evident between health controls and oral cancer patients. These proinflammatory 
cytokines may be used as biomarkers indicating carcinogenic transformation from oral 
preneoplastic lesions to oral cancer enabling earlier detection and providing a screening method 
more relevant to the Alaska Native population and particularly iqmik users. Another use for
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saliva biomarkers, such as these proinflammatory cytokines, may also be preliminary 
biomarkers, identified prior to treatment, for a measure of efficacy of therapy treatments for 
patients with oral cancer. A future study may benefit from using the biomarker levels identified 
in the recruited participants with primary oral cancers, before treatment, as a comparison to 
evaluate the effectiveness a variety of treatment methods.
Data from the different sub-groups will provide information on the pro-inflammatory 
environment created by different tobacco products used, such as iqmik. Our laboratory has 
demonstrated that NF-k B dependent proinflammatory cytokine gene expression is significantly 
elevated in HGEP (Figure 3.1) following exposure to iqmik saliva extracts compared to the 
saliva control. Our data suggests that there is a greater gene expression of the NF-kB dependent 
proinflammatory cytokines IL-1, IL-6, IL-8, COX-2 and TNF-a following iqmik saliva extract 
exposure than tobacco extract exposure, but a study of this nature has not been performed yet on 
iqmik users saliva. Thus, the sample size may not be sufficient to identify a significant difference 
between tobacco products, but can be used to determine if a larger study in the future would be 
feasible to identify a significant difference (19).
3.9 Conclusions and future directions
Biomarker data as a method for measuring biological events, such as the development of cancer, 
is extremely useful and important. The best example of this to date is the analysis of TP53 
mutations in lung cancer of smokers and non-smokers. The pattern of mutations in non-smokers 
is very different from the pattern found in smokers, closely resembling the pattern in other non­
tobacco-related cancers (35, 36).
A case-control study allows for data collection at only one point so the data only examines one 
outcome and the temporal sequence of exposure can be difficult to determine (27). A nested
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case-control study, while being more expensive and more involved study to execute, would 
allow for a more accurate temporal data collection and the study participants would be recruited 
into a larger cohort that would be beneficial for future study, such as measuring the effectiveness 
of treatments with biomarker data (28).
The results of this preliminary biomarker research will quantify the inflammatory environment 
present in cigarette, SLT and iqmik users oral cavity as well as the biological relevance of the 
NF-kB dependent cytokines as markers of cancer development in tobacco users, particularly 
iqmik users, which have never been studied before. The data will be accessible to design larger 
studies in the future to verify population and tobacco product relevant diagnostic markers in 
patients with OPML, as precursors to oral cancer. The information from this proposed research 
will be available to regional health authorities and researchers to develop cost effective assays 
for early detection of OPLM and oral cancer.
The biomarker data may also be used to develop a tobacco cessation intervention for the 
participants of the study, that consented to being contacted. Iqmik is perceived as safer 
alternative than other tobacco products and Alaska Native women have been reported to switch 
from other tobacco products to iqmik during pregnancy (37). Very little research to date has 
explored the health effects of iqmik use, so there is very little data available to develop a 
biologically informed, evidence-based cessation program for iqmik users. Additionally, banked 
samples can be utilized in the future to investigate the effect of tobacco products on oral cancer 
progression and investigate additional oral cancer biomarkers. This proposed pilot study will 
provide a foundation for future tobacco and oral cancer biomarker research in Alaska focused on 
addressing health concerns related to tobacco use in Alaska Native peoples.
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ILIA IL1B IL6 IL8 PTGS2
Figure 3.1 Iqmik and tobacco altered NF-k B proinflammatory gene targets. NF-kB signaling 
target gene expression, IL-1A, IL-1B, IL-6, IL-8 and PTGS2 (COX2) was measured by qPCR 
with RT2 Profiler PCR Array following a 4hr exposure of differentiated HGEP to diluted iqmik 
and tobacco saliva extracts, and data analyzed using RT PCR Array Data Analysis freeware. 
Genes were reported as altered using both fold change of >1.3 and p < 0.2. Data are 
representative of triplicate experiments and expressed as fold regulation (positive fold regulation 
as 2-aact and negative fold regulation as -1/2-AACT).
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Figure 3.2 Recruitment strategy. The anticipated recruitment for all oral cancer participants and 
oral cancer-free participants as described in ‘Participants’.
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Figure 3.3 A general principle of ELISA. The saliva supernatants will be transferred to antibody- 
coated 96-well plates. The captured cytokine will be detected with a specific primary antibody 
and secondary HRP conjugate antibody. A chromogenic substrate will be added to each well and 
the resulting color will be read as absorbance.
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Conclusion
The findings reported herein identify iqmik as a unique health hazard compared to other tobacco 
products. The addition of punk ash influences the biochemical make-up of iqmik, making it 
distinct from other smokeless tobacco (SLT) products. The punk ash and tobacco mixture has a 
pH of 10.02 when extracted in artificial human saliva, a similar pH to betel quid when mixed 
with slaked lime. The pH of the mixture influences the amount of bioavailable nicotine in the 
mixture and accounts for the higher levels of cotinine, the major metabolite of nicotine, found in 
users (1). The punk ash also introduces pro-inflammatory toxic metals into the mixture that are 
not found in the air-cured tobacco alone, including Cd, Co and Ni, which we have demonstrated 
accumulate in differentiated human gingival epithelial cells (HGEP). These metals contribute to 
the significant endogenous reactive oxygen species (ROS) production observed in HGEP 
following treatment with iqmik artificial saliva extracts. Metal toxicity is a stimulus for oxidative 
stress leading to inflammation through the activation of a key redox-regulated transcription 
factor nuclear factor-KB (NF-k B), which plays a major role in pro-inflammatory and stress 
responses. NF-kB and its signaling targets, such as COX-2, IL-6 and IL-8, are expressed at high 
levels in many epithelial cancers including head and neck squamous cell carcinoma (HNSCC)
(2).
Squamous cell carcinoma accounts for 90% of all oral cancers (3). In the initial phases of oral 
cancer, one thought is that mutations accumulate in the basal layer of the epithelium (3). The oral 
epithelial basal layer includes cells with a self-renewing capacity. These cells are responsible for 
renewing the epithelial lining and regenerate rapidly when damaged. Under physiologic 
conditions these cells differentiate as they move through the layers of epithelium and become 
keratinocytes in the gingival area. An alternate theory for the development of HNSCC is that an
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accumulation of mutations within differentiated cells leads to their regaining the capacity to self- 
renew (4).
Studies have found that long-term SLT exposure can cause disturbances in the differentiation 
process of the oral epithelium. Three-dimensional epithelial cultures exposed to long-term 
treatments of Swedish snuff showed weaker expression of keratin 10 than the control samples 
that expressed keratin 10 in the upper two thirds of the epithelium (5,6). In our study we 
demonstrated differentiation of the HGEP prior to treatment by the increasing expression of 
keratin 10. A future study should investigate the effect of long-term iqmik treatments on 
keratinization markers, such as keratin 10 and involucrin (5).
The main events leading to cancer are chronic inflammation leading to genetic alteration, and 
malignant transformation; ROS generation is associated with all these conditions (7). Oral 
squamous cell carcinoma (OSCC) patients have increased levels of ROS and reactive nitrogen 
species (RNS) in their saliva and the salivary antioxidant content is significantly reduced 
compared to healthy controls. Salivary DNA and proteins are more oxidized in OSCC patients 
than healthy controls, and the combination of ROS, RNS and depleted antioxidants promotes 
OSCC (8-10).
Exposure of HGEP to air-cured tobacco or iqmik artificial saliva extracts results in 
significantly more ROS generation than artificial saliva alone. The air cured tobacco extracts are 
similar to hydrogen peroxide, but iqmik extracts produce significantly more ROS than hydrogen 
peroxide. Exposure to punk ash alone does not significantly increase ROS. Levels of ROS seen 
in cells exposed to iqmik artificial saliva extracts are greater than the sum of ROS produced upon 
exposure to artificial saliva extracts of punk ash alone and air-cured tobacco alone, suggesting a 
synergistic effect of the punk ash-tobacco mixture. In regard to the relative contribution of each
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metal, Cd, Co, and Ni, in ROS formation in differentiated HGEP, Co exposure produces similar 
levels of ROS to that of iqmik and 10 time that seen with saliva alone. The concentration of Co 
that differentiated HGEP are exposed to in artificial saliva extracts of iqmik is likely contributing 
to the high levels of ROS produced in response to iqmik exposure.
As previously identified by Pappas et al., (11) punk ash has significantly more Cd, Co and Ni 
than the air-cured tobacco leaf, accounting for the elevated levels of carcinogenic metals in 
iqmik. The extraction efficiency of Cd, Co and Ni is pH dependent. In an alkaline solution, Cd, 
Co and Ni form insoluble hydroxide salts (12). This trend is evident when comparing the 
concentrations of metals in artificial saliva extracts of iqmik, air-cured tobacco and punk ash. 
Studies of other alkaline ash extracts have shown similar results. Cd is minimally soluble 
between pH ranges 10.5 and 13 in fly ash (13). The pH of the punk ash extracts and iqmik 
extracts are just outside the range of minimal solubility for Cd. Based on the similarity of 
solubility constants for the metal hydroxides, Co and Ni are likely to have similar pH ranges for 
solubility. This is further confirmed by the fact that punk ash has a higher concentration of 
metals than air-cured tobacco alone, but the alkaline artificial saliva extracts of punk ash have 
lower levels of Cd and Co than artificial saliva extracts of air-cured tobacco.
The minimal risk levels published by the Agency for Toxic Substances and Disease Registry 
(ASTDR) are 0.0005 mg/kg/day intermediate oral exposure and 0.0001 mg/kg/day chronic oral 
exposure for Cd, 0.01 mg/kg/day intermediate oral exposure for Co, 0.0002 mg/m3 intermediate 
inhaled exposure and 0.00009 mg/m3 chronic inhaled exposure for Ni. Intermediate exposure is 
15-364 days; chronic exposure is greater than 1 year. The minimal risk level for Ni from oral 
exposure has not been determined, but water sources have a median Ni range of 0.5 to 6 p,g/L. 
The EPA requires drinking water to have less than 5 |ig/L of Cd, and the average reported level
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of Co in drinking water is 2 p,g/L. A 30 min artificial saliva extract of iqmik contains 1/3 of the 
maximum recommended amount of Cd in drinking water, and exceeds the average amount of Co 
and Ni in drinking water by 5 and 10 fold, respectively (14-16).
The accumulation of metals in the cells shows a very different trend from the saliva extraction 
efficiencies. HGEP exposed to punk ash extracts have the greatest metal absorption for Cd, Co 
and Ni. Active transport of the metals into the cells occurs primarily in the punk ash and iqmik 
saliva extract treated HGEP. The pH of the punk ash and iqmik saliva extracts are both basic. To 
compensate for the alkalinity of the external environment, HGEP, like other cells, would try to 
maintain their cytosol close to physiological pH. To maintain a more neutral internal 
environment a net internal accumulation of H+ must occur (17,18). Na+/H+ antiporters are 
actively involved in intracellular homeostasis, but in an alkaline environment the antiporter must 
be electrogenic rather than electroneutral. The internal transmembrane electrical gradient must be 
negative to support a larger influx of H+ to a small efflux of Na+ (18). The negative internal 
environment created within the cell may be influencing the transport of divalent transition metals 
across the cell membrane. Divalent metals are moved across the membrane by members of the 
solute carrier (SLC) group, many of which function as cotransporters. The SLC family uses the 
H+ electrochemical gradient to transport a broad range of divalent metal ions, including Fe2+, 
Cd2+, Co2+, Ni2+, Zn2+, and Pb2+ (19-21). It is possible that the alkaline external environment 
created by the exposure to punk ash or iqmik saliva extracts promotes the accumulation of Cd,
Co and Ni in HGEP.
Heavy metals, such as Cd, Co and Ni, are carcinogenic through a variety of mechanisms, 
including oxidative damage to DNA, as well as inhibiting the repair of damaged DNA. Cd, Co 
and Ni all contribute to the production of free radicals in cells. Many divalent metals participate
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in a Fenton-like reaction to produce free radicals in the cell (7,22). Cd also binds to sulfhydryls 
like glutathione thus depleting glutathione stores, contributing to its toxicity and allowing ROS 
to propagate in the cell (23). Metal toxicity is a stimulus for oxidative stress through the 
propagation of ROS leading to inflammation by activating redox-regulated transcription factors, 
including NF-kB, which plays a major role in inflammation, stress responses and oral cancer 
progression (2).
Increased tumor growth, metastasis and decreased survival rates of oral cancer are the 
consequence of alterations in host immune surveillance, inflammation, angiogenesis and 
metabolism. Tumor development requires proinflammatory, proangiogenesis and 
immunoregulatory signaling. NF-k B is a redox-sensitive transcription factor that is elevated by 
tobacco use and chronic inflammatory conditions. The overexpression of NF-k B correlates with 
the overexpression of proinflammatory, proangiogenic and anti-apoptotic signaling which are 
prevalent in HNSCC (24). Protein levels of NF-k B gradually increase from premalignant lesions 
to invasive cancer (4). Therefore, NF-k B signaling is suggested to play an important role in the 
early stages of head and neck cancer.
Iqmik exposure altered the expression of 41 of 84 NF-kB signaling target genes tested 
compared to the saliva treatment alone. This set of altered genes was defined using the 
parameters of Huggins et al. (25), which identify more biologically meaningful sets of altered 
genes than using p-value alone or more strict fold-change and p-value parameters (26). Genes 
altered by iqmik exposure are involved in evading and inducing apoptosis, angiogenesis, 
blocking differentiation, proliferation, coagulation and inflammation. Tobacco exposure altered 
31 of the 84 genes tested compared to the saliva treatment alone. Iqmik exposure generated a 
unique gene expression profile. Nine genes that were altered by both iqmik exposure and tobacco
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exposure showed increased expression following iqmik exposure, but decreased expression 
following tobacco exposure, and 24 of the altered genes were more significantly alter by iqmik 
than by tobacco, based on the Huggins et al., (25) significance parameters. These data support 
the hypothesis that iqmik differentially alters the expression profile of NF-k B regulated genes 
compared to tobacco leaf alone. These data also support the conclusion that iqmik is a unique 
health hazard which requires an exposure specific set of biomarkers for a population relevant 
early detection strategy.
COX2, a key signaling target of NF-k B, is not expressed under normal physiologic conditions, 
but is widely overexpressed in pathophysiologic conditions, such as cancer (27,28). In the 
experiments presented herein, short-term exposure to iqmik resulted in an up-regulation of the 
gene expression of PTGS2, the gene encoding COX2, greater than tobacco exposure alone. 
Animal studies have demonstrated an up-regulation of COX2 at the site of SLT application (29). 
COX2 activation is an early event during carcinogenesis. COX2 overexpression is evident in oral 
mucosal lesions with an increasing level of COX2 expressed from hyperplasia to dysplasia with 
the highest levels reported in HNSCC (30). The overexpression of COX2 alters cell adhesion, the 
response to signals from growth regulators and inhibits apoptosis (31). Prostaglandins, the 
products of COX2 enzyme activity, activate nuclear hormone receptors that regulate intracellular 
calcium levels and increase cellular proliferations rates (27). Prostaglandins also promote 
angiogenesis and inhibit immune surveillance (27,32). Studies in which human volunteers used 
SLT demonstrated a significant increase in IL-1 a  and prostaglandin E2, a downstream product of 
COX2 enzymatic activity, as well as the development of oral lesions in over half the volunteers 
by day 7 (6,33,34). In contrast, COX2 deficiency in mice protects against the formation of 
epithelial tumors (35,36). The reduced tumor formation is in response to premature terminal
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differentiation of epithelial cells into keratinocytes. Keratins 1 and 10, indicators of commitment 
to differentiate, are both expressed in basal cells in theses COX-2 deficient mice (35). The data 
on the increased expression of PTGS2 following iqmik exposure compared to tobacco leaf alone 
supports the uniqueness of iqmik exposure on the pathophysiology of HGEP, and supports the 
idea that iqmik can create a cellular environment which increases the risk for malignant 
transformation.
A major public health concern is the rate of incidence and of mortality from HNSCC in Alaska 
Natives. The incidence of oral cancer is estimated to be rising by 6.5% annually for Alaska 
Natives. Alaska Natives have a mortality rate of 6.1 cases per 100,000 per year for oral cancers. 
The most common diagnostic tool is visual inspection to detect oral cancers, even though there is 
little evidence that this method reduces the incidence of or mortality from oral cancers (37,38). 
The data presented herein suggests that an alternate screening strategy based on a population 
specific set of biomarkers reflective of SLT use in Alaska could be developed to improve early 
detection of oral lesions which have the potential to proceed through malignant transformation.
Iqmik induces more cancer associated genes than tobacco alone including many of the key 
NF-kB dependent inflammatory and proangiogenic cytokines including IL-1, IL-6, IL-8, GM- 
CSF and members of the TNF family. The proposed case-control study to test the levels of these 
inflammatory cytokines in saliva samples collected from participants without or with identifiable 
HNSCC and who self-report the use of SLT (iqmik), cigarettes or no tobacco product use is 
predicted to demonstrate a significant difference between healthy controls and HNSCC patients. 
Previous studies have demonstrated a significant increase in levels of NF-k B dependent 
proinflammatory cytokines in the saliva of HNSCC patients compared to controls (39,40). These 
same cytokines are elevated in oral preneoplastic lesions compared to controls. These
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proinflammatory cytokines may therefore be useful as biomarkers indicative of oral 
preneoplastic lesion to HNSCC transformation enabling earlier detection with an evidence-based 
screening method which may also be useful as a strategy for tracking the effectiveness of 
treatments for patients with HNSCC.
Although Iqmik is perceived as a safer alternative to other tobacco products (41), iqmik is a 
greater source of heavy metals, such as Cd, Co and Ni, than air-cured tobacco leaf. HGEP 
accumulate more Cd, Co and Ni from the punk ash component of iqmik than from the air-cured 
tobacco. These metals are identified carcinogens that have the capacity to accumulate in cells 
and generate and propagate the production of endogenous ROS. The results of this study help 
elucidate the unique properties of iqmik and stress the necessity to understand the biological 
response to iqmik use through future studies. The proposed case-control pilot study will provide 
a foundation for future tobacco and HNSCC research in Alaska to address health concerns 
related to tobacco use in Alaska Natives.
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